name,category,termsAHA1, activator of heat shock 90kDa protein ATPase homolog 2 (yeast),INTERPRO[450013752$IPR015310:Activator of Hsp90 ATPase, N-terminal]
AHA1, activator of heat shock 90kDa protein ATPase homolog 2 (yeast),SP_PIR_KEYWORDS[790000053$alternative splicing, 790000288$Chaperone, 790000356$complete proteome, 790001212$polymorphism, 790001450$stress response]
AHA1, activator of heat shock 90kDa protein ATPase homolog 2 (yeast),UP_SEQ_FEATURE[850003671$chain:Activator of 90 kDa heat shock protein ATPase homolog 2, 850117295$sequence variant, 850118574$splice variant]
ATPase, Ca++ transporting, type 2C, member 1,INTERPRO[450000595$IPR000695:ATPase, P-type, H+ transporting proton pump, 450001556$IPR001757:ATPase, P-type, K/Mg/Cd/Cu/Zn/Na/Ca/Na/H-transporter, 450003534$IPR004014:ATPase, P-type cation-transporter, N-terminal, 450005281$IPR005834:Haloacid dehalogenase-like hydrolase, 450005504$IPR006068:ATPase, P-type cation-transporter, C-terminal, 450005835$IPR006413:ATPase, P-type, calcium-transporting, PMR1-type, 450007545$IPR008250:ATPase, P-type, ATPase-associated region, 450016587$IPR018303:ATPase, P-type phosphorylation site]
ATPase, Ca++ transporting, type 2C, member 1,OMIM_DISEASE[520000549$benign chronic pemphigus (Hailey-Hailey disease), 520002207$Hailey-Hailey disease]
ATPase, Ca++ transporting, type 2C, member 1,PIR_SUPERFAMILY[630001445$PIRSF001297:Na(+)/K(+)-transporting ATPase alpha chain]
ATPase, Ca++ transporting, type 2C, member 1,SP_PIR_KEYWORDS[790000053$alternative splicing, 790000138$atp-binding, 790000211$calcium, 790000215$calcium transport, 790000356$complete proteome, 790000446$disease mutation, 790000624$golgi apparatus, 790000743$hydrolase, 790000798$ion transport, 790000899$magnesium, 790000919$membrane, 790000937$metal-binding, 790001063$nucleotide-binding, 790001162$phosphoprotein, 790001212$polymorphism, 790001555$transmembrane, 790001558$transport]
ATPase, Ca++ transporting, type 2C, member 1,UP_SEQ_FEATURE[850000003$active site:4-aspartylphosphate intermediate, 850009067$chain:Calcium-transporting ATPase type 2C member 1, 850105918$metal ion-binding site:Calcium 2, 850105922$metal ion-binding site:Calcium 2; via carbonyl oxygen, 850106107$metal ion-binding site:Magnesium, 850117294$sequence conflict, 850117295$sequence variant, 850118574$splice variant, 850118577$topological domain:Cytoplasmic, 850118590$topological domain:Lumenal, 850118623$transmembrane region]
ATPase, H+ transporting, lysosomal 13kDa, V1 subunit G2,INTERPRO[450004593$IPR005124:Vacuolar (H+)-ATPase G subunit]
ATPase, H+ transporting, lysosomal 13kDa, V1 subunit G2,KEGG_PATHWAY[470038741$hsa00190:Oxidative phosphorylation, 470038896$hsa05110:Vibrio cholerae infection, 470038897$hsa05120:Epithelial cell signaling in Helicobacter pylori infection]
ATPase, H+ transporting, lysosomal 13kDa, V1 subunit G2,PIR_SUPERFAMILY[630005500$PIRSF005577:V-type ATPase, subunit G]
ATPase, H+ transporting, lysosomal 13kDa, V1 subunit G2,SP_PIR_KEYWORDS[790000356$complete proteome, 790000739$Hydrogen ion transport, 790000798$ion transport, 790001558$transport]
ATPase, H+ transporting, lysosomal 13kDa, V1 subunit G2,UP_SEQ_FEATURE[850099816$chain:V-type proton ATPase subunit G 2]
ATPase, H+ transporting, lysosomal 14kDa, V1 subunit F,INTERPRO[450005225$IPR005772:ATPase, V1 complex, subunit F, eukaryotic, 450007526$IPR008218:ATPase, V1/A1 complex, subunit F]
ATPase, H+ transporting, lysosomal 14kDa, V1 subunit F,KEGG_PATHWAY[470038741$hsa00190:Oxidative phosphorylation, 470038896$hsa05110:Vibrio cholerae infection, 470038897$hsa05120:Epithelial cell signaling in Helicobacter pylori infection]
ATPase, H+ transporting, lysosomal 14kDa, V1 subunit F,PIR_SUPERFAMILY[630012715$PIRSF015945:ATPase_V1_F_euk, 630012716$PIRSF015945:V-type ATPase, subunit F]
ATPase, H+ transporting, lysosomal 14kDa, V1 subunit F,SP_PIR_KEYWORDS[790000356$complete proteome, 790000739$Hydrogen ion transport, 790000798$ion transport, 790001212$polymorphism, 790001558$transport]
ATPase, H+ transporting, lysosomal 14kDa, V1 subunit F,UP_SEQ_FEATURE[850099812$chain:V-type proton ATPase subunit F, 850117294$sequence conflict, 850117295$sequence variant]
BCL2/adenovirus E1B 19kDa interacting protein 1,INTERPRO[450005055$IPR005606:Sec20]
BCL2/adenovirus E1B 19kDa interacting protein 1,KEGG_PATHWAY[470038838$hsa04130:SNARE interactions in vesicular transport]
BCL2/adenovirus E1B 19kDa interacting protein 1,SP_PIR_KEYWORDS[790000053$alternative splicing, 790000109$Apoptosis, 790000344$coiled coil, 790000356$complete proteome, 790000499$endoplasmic reticulum, 790000510$er-golgi transport, 790000919$membrane, 790001212$polymorphism, 790001555$transmembrane, 790001558$transport]
BCL2/adenovirus E1B 19kDa interacting protein 1,UP_SEQ_FEATURE[850100220$chain:Vesicle transport protein SEC20, 850106259$mutagenesis site, 850117294$sequence conflict, 850117295$sequence variant, 850118574$splice variant, 850118577$topological domain:Cytoplasmic, 850118590$topological domain:Lumenal, 850118623$transmembrane region]
C-type lectin domain family 17, member A,INTERPRO[450001149$IPR001304:C-type lectin, 450014523$IPR016186:C-type lectin-like, 450016659$IPR018378:C-type lectin, conserved site]
C-type lectin domain family 17, member A,SMART[760000026$SM00034:CLECT]
C-type lectin domain family 17, member A,SP_PIR_KEYWORDS[790000356$complete proteome, 790000848$Lectin, 790000919$membrane, 790001555$transmembrane]
C-type lectin domain family 17, member A,UP_SEQ_FEATURE[850008692$chain:C-type lectin and transmembrane domain- containing protein FLJ45910, 850103184$domain:C-type lectin, 850118623$transmembrane region]
CD19 molecule,BBID[10000099$78.B_Cell_Development]
CD19 molecule,INTERPRO[450003160$IPR003599:Immunoglobulin subtype, 450006486$IPR007110:Immunoglobulin-like]
CD19 molecule,KEGG_PATHWAY[470038867$hsa04640:Hematopoietic cell lineage, 470038870$hsa04662:B cell receptor signaling pathway, 470038919$hsa05340:Primary immunodeficiency]
CD19 molecule,OMIM_DISEASE[520000342$Antibody deficiency due to defect in CD19]
CD19 molecule,PIR_SUPERFAMILY[630013414$PIRSF016630:CD19]
CD19 molecule,SMART[760000357$SM00409:IG]
CD19 molecule,SP_PIR_KEYWORDS[790000152$B-cell, 790000356$complete proteome, 790000447$disulfide bond, 790000616$glycoprotein, 790000768$Immunoglobulin domain, 790000919$membrane, 790001162$phosphoprotein, 790001212$polymorphism, 790001304$repeat, 790001405$signal, 790001469$surface antigen, 790001555$transmembrane, 790001556$transmembrane protein]
CD19 molecule,UP_SEQ_FEATURE[850007065$chain:B-lymphocyte antigen CD19, 850102883$disulfide bond, 850104356$domain:Ig-like C2-type 1, 850104367$domain:Ig-like C2-type 2, 850105770$glycosylation site:N-linked (GlcNAc...), 850106258$modified residue, 850117294$sequence conflict, 850117295$sequence variant, 850117814$signal peptide, 850118577$topological domain:Cytoplasmic, 850118583$topological domain:Extracellular, 850118623$transmembrane region]
CDC42 small effector 2,INTERPRO[450000079$IPR000095:PAK-box/P21-Rho-binding]
CDC42 small effector 2,SMART[760000256$SM00285:PBD]
CDC42 small effector 2,SP_PIR_KEYWORDS[790000264$cell membrane, 790000268$cell shape, 790000356$complete proteome, 790000407$cytoplasm, 790000410$cytoskeleton, 790000881$lipoprotein, 790000919$membrane, 790001100$palmitate, 790001136$phagocytosis]
CDC42 small effector 2,UP_SEQ_FEATURE[850010191$chain:CDC42 small effector protein 2, 850102566$compositionally biased region:Poly-Arg, 850103411$domain:CRIB, 850105898$lipid moiety-binding region:S-palmitoyl cysteine]
DENN/MADD domain containing 4C,INTERPRO[450001049$IPR001194:DENN, 450002551$IPR002885:Pentatricopeptide repeat, 450004581$IPR005112:dDENN, 450004582$IPR005113:uDENN]
DENN/MADD domain containing 4C,SMART[760000702$SM00799:DENN, 760000703$SM00800:uDENN, 760000704$SM00801:dDENN]
DENN/MADD domain containing 4C,SP_PIR_KEYWORDS[790000053$alternative splicing, 790000356$complete proteome, 790000616$glycoprotein, 790000919$membrane, 790001162$phosphoprotein, 790001212$polymorphism, 790001555$transmembrane]
DENN/MADD domain containing 4C,UP_SEQ_FEATURE[850014833$chain:DENN domain-containing protein 4C, 850102581$compositionally biased region:Poly-Ser, 850103503$domain:dDENN, 850103514$domain:DENN, 850105606$domain:uDENN, 850105770$glycosylation site:N-linked (GlcNAc...), 850106258$modified residue, 850116805$repeat:PPR, 850117294$sequence conflict, 850117295$sequence variant, 850118574$splice variant, 850118623$transmembrane region]
DEP domain containing 1B,INTERPRO[450000169$IPR000198:RhoGAP, 450000504$IPR000591:Pleckstrin/G-protein, interacting region, 450010816$IPR011991:Winged helix repressor DNA-binding]
DEP domain containing 1B,SMART[760000041$SM00049:DEP, 760000293$SM00324:RhoGAP]
DEP domain containing 1B,SP_PIR_KEYWORDS[790000356$complete proteome, 790000640$GTPase activation, 790001212$polymorphism]
DEP domain containing 1B,UP_SEQ_FEATURE[850014891$chain:DEP domain-containing protein 1B, 850102577$compositionally biased region:Poly-Lys, 850103515$domain:DEP, 850105183$domain:Rho-GAP, 850117294$sequence conflict, 850117295$sequence variant]
DnaJ (Hsp40) homolog, subfamily C, member 4,INTERPRO[450001438$IPR001623:Heat shock protein DnaJ, N-terminal, 450002720$IPR003095:Heat shock protein DnaJ, 450014048$IPR015609:Molecular chaperone, heat shock protein, Hsp40, DnaJ, 450016538$IPR018253:Heat shock protein DnaJ, conserved site]
DnaJ (Hsp40) homolog, subfamily C, member 4,SMART[760000243$SM00271:DnaJ]
DnaJ (Hsp40) homolog, subfamily C, member 4,SP_PIR_KEYWORDS[790000288$Chaperone, 790000356$complete proteome, 790000919$membrane, 790001555$transmembrane]
DnaJ (Hsp40) homolog, subfamily C, member 4,UP_SEQ_FEATURE[850016181$chain:DnaJ homolog subfamily C member 4, 850104487$domain:J, 850118623$transmembrane region]
ER lipid raft associated 2,INTERPRO[450000970$IPR001107:Band 7 protein]
ER lipid raft associated 2,SMART[760000216$SM00244:PHB]
ER lipid raft associated 2,SP_PIR_KEYWORDS[790000053$alternative splicing, 790000356$complete proteome, 790000445$direct protein sequencing, 790000499$endoplasmic reticulum, 790000616$glycoprotein, 790000919$membrane, 790001212$polymorphism, 790001409$Signal-anchor, 790001555$transmembrane]
ER lipid raft associated 2,UP_SEQ_FEATURE[850017781$chain:Erlin-2, 850105770$glycosylation site:N-linked (GlcNAc...), 850106259$mutagenesis site, 850112303$region of interest:Interaction with ERLIN1, 850117294$sequence conflict, 850117295$sequence variant, 850118574$splice variant, 850118577$topological domain:Cytoplasmic, 850118590$topological domain:Lumenal, 850118623$transmembrane region]
G protein regulated inducer of neurite outgrowth 1,SP_PIR_KEYWORDS[790000053$alternative splicing, 790000264$cell membrane, 790000267$cell projection, 790000356$complete proteome, 790000881$lipoprotein, 790000919$membrane, 790001100$palmitate, 790001162$phosphoprotein, 790001212$polymorphism]
G protein regulated inducer of neurite outgrowth 1,UP_SEQ_FEATURE[850020258$chain:G protein-regulated inducer of neurite outgrowth 1, 850105898$lipid moiety-binding region:S-palmitoyl cysteine, 850106258$modified residue, 850112370$region of interest:Interaction with GNAO1, 850117294$sequence conflict, 850117295$sequence variant, 850118574$splice variant]
GATA zinc finger domain containing 1,INTERPRO[450000580$IPR000679:Zinc finger, GATA-type]
GATA zinc finger domain containing 1,OMIM_DISEASE[520003072$Many sequence variants affecting diversity of adult human height]
GATA zinc finger domain containing 1,SMART[760000352$SM00401:ZnF_GATA]
GATA zinc finger domain containing 1,SP_PIR_KEYWORDS[790000356$complete proteome, 790000937$metal-binding, 790001212$polymorphism, 790001648$zinc, 790001651$zinc-finger]
GATA zinc finger domain containing 1,UP_SEQ_FEATURE[850020704$chain:GATA zinc finger domain-containing protein 1, 850102517$compositionally biased region:Gly-rich, 850117294$sequence conflict, 850117295$sequence variant, 850118822$zinc finger region:GATA-type]
GTPase, IMAP family member 2,INTERPRO[450006113$IPR006703:AIG1]
GTPase, IMAP family member 2,SP_PIR_KEYWORDS[790000356$complete proteome, 790000639$gtp-binding, 790000919$membrane, 790001063$nucleotide-binding, 790001212$polymorphism, 790001555$transmembrane]
GTPase, IMAP family member 2,UP_SEQ_FEATURE[850022634$chain:GTPase IMAP family member 2, 850106296$nucleotide phosphate-binding region:GTP, 850117295$sequence variant, 850118623$transmembrane region]
HECT, UBA and WWE domain containing 1,INTERPRO[450000382$IPR000449:Ubiquitin-associated/translation elongation factor EF1B, N-terminal, 450000485$IPR000569:HECT, 450001756$IPR001983:Translationally controlled tumour-associated TCTP, 450003680$IPR004170:WWE domain, 450009377$IPR010309:E3 ubiquitin ligase, region of unknown function DUF908, 450009382$IPR010314:E3 ubiquitin ligase, region of unknown function DUF913, 450010223$IPR011323:Mss4/translationally controlled tumour-associated TCTP, 450014352$IPR015940:Ubiquitin-associated/translation elongation factor EF1B, N-terminal, eukaryote, 450016403$IPR018103:Translationally controlled tumour protein, conserved site]
HECT, UBA and WWE domain containing 1,KEGG_PATHWAY[470038837$hsa04120:Ubiquitin mediated proteolysis]
HECT, UBA and WWE domain containing 1,OMIM_DISEASE[520003207$Mental retardation, X-linked syndromic 10, 520003209$Mental retardation, X-linked syndromic, Turner type]
HECT, UBA and WWE domain containing 1,SMART[760000104$SM00119:HECTc, 760000144$SM00165:UBA]
HECT, UBA and WWE domain containing 1,SP_PIR_KEYWORDS[790000002$3d-structure, 790000012$acetylation, 790000053$alternative splicing, 790000316$chromosomal rearrangement, 790000356$complete proteome, 790000407$cytoplasm, 790000434$differentiation, 790000446$disease mutation, 790000466$dna-binding, 790000859$ligase, 790000930$mental retardation, 790001065$nucleus, 790001162$phosphoprotein, 790001212$polymorphism, 790001593$ubl conjugation pathway]
HECT, UBA and WWE domain containing 1,UP_SEQ_FEATURE[850000085$active site:Glycyl thioester intermediate, 850016653$chain:E3 ubiquitin-protein ligase HUWE1, 850102458$compositionally biased region:Asp-rich, 850102507$compositionally biased region:Glu-rich, 850102605$compositionally biased region:Thr-rich, 850104105$domain:HECT, 850105597$domain:UBA, 850105736$domain:WWE, 850105852$helix, 850106258$modified residue, 850106259$mutagenesis site, 850117161$repeat:UIM, 850117294$sequence conflict, 850117295$sequence variant, 850118574$splice variant, 850118575$strand, 850118624$turn]
IQ motif and Sec7 domain 2,INTERPRO[450000040$IPR000048:IQ calmodulin-binding region, 450000787$IPR000904:SEC7-like, 450001635$IPR001849:Pleckstrin homology]
IQ motif and Sec7 domain 2,KEGG_PATHWAY[470038841$hsa04144:Endocytosis]
IQ motif and Sec7 domain 2,SMART[760000009$SM00015:IQ, 760000194$SM00222:Sec7, 760000205$SM00233:PH]
IQ motif and Sec7 domain 2,SP_PIR_KEYWORDS[790000053$alternative splicing, 790000344$coiled coil, 790000356$complete proteome, 790000407$cytoplasm, 790001162$phosphoprotein]
IQ motif and Sec7 domain 2,UP_SEQ_FEATURE[850026751$chain:IQ motif and SEC7 domain-containing protein 2, 850102540$compositionally biased region:His-rich, 850102572$compositionally biased region:Poly-Glu, 850102586$compositionally biased region:Pro-rich, 850104439$domain:IQ, 850104979$domain:PH, 850105336$domain:SEC7, 850106258$modified residue, 850118574$splice variant]
KDEL (Lys-Asp-Glu-Leu) endoplasmic reticulum protein retention receptor 2,INTERPRO[450000112$IPR000133:ER lumen protein retaining receptor]
KDEL (Lys-Asp-Glu-Leu) endoplasmic reticulum protein retention receptor 2,KEGG_PATHWAY[470038896$hsa05110:Vibrio cholerae infection]
KDEL (Lys-Asp-Glu-Leu) endoplasmic reticulum protein retention receptor 2,SP_PIR_KEYWORDS[790000053$alternative splicing, 790000356$complete proteome, 790000499$endoplasmic reticulum, 790000510$er-golgi transport, 790000919$membrane, 790001266$protein transport, 790001301$receptor, 790001555$transmembrane, 790001558$transport]
KDEL (Lys-Asp-Glu-Leu) endoplasmic reticulum protein retention receptor 2,UP_SEQ_FEATURE[850017753$chain:ER lumen protein retaining receptor 2, 850117294$sequence conflict, 850118574$splice variant, 850118577$topological domain:Cytoplasmic, 850118590$topological domain:Lumenal, 850118623$transmembrane region]
KIAA1530,INTERPRO[450016882$IPR018610:Protein of unknown function DUF2043]
KIAA1530,SP_PIR_KEYWORDS[790000053$alternative splicing, 790000344$coiled coil, 790000356$complete proteome, 790001162$phosphoprotein, 790001212$polymorphism]
KIAA1530,UP_SEQ_FEATURE[850075552$chain:Uncharacterized protein KIAA1530, 850106258$modified residue, 850117295$sequence variant, 850118574$splice variant]
KIAA1539,SP_PIR_KEYWORDS[790000053$alternative splicing, 790000356$complete proteome]
KIAA1539,UP_SEQ_FEATURE[850075553$chain:Uncharacterized protein KIAA1539, 850118574$splice variant]
Kruppel-like factor 2 (lung),COG_ONTOLOGY[90000073$General function prediction only]
Kruppel-like factor 2 (lung),INTERPRO[450006475$IPR007087:Zinc finger, C2H2-type, 450011731$IPR013087:Zinc finger, C2H2-type/integrase, DNA-binding, 450014303$IPR015880:Zinc finger, C2H2-like]
Kruppel-like factor 2 (lung),SMART[760000323$SM00355:ZnF_C2H2]
Kruppel-like factor 2 (lung),SP_PIR_KEYWORDS[790000020$activator, 790000356$complete proteome, 790000466$dna-binding, 790000937$metal-binding, 790001065$nucleus, 790001212$polymorphism, 790001304$repeat, 790001539$Transcription, 790001543$transcription regulation, 790001648$zinc, 790001651$zinc-finger]
Kruppel-like factor 2 (lung),UP_SEQ_FEATURE[850027607$chain:Krueppel-like factor 2, 850102565$compositionally biased region:Poly-Ala, 850102573$compositionally biased region:Poly-Gly, 850102580$compositionally biased region:Poly-Pro, 850117294$sequence conflict, 850117295$sequence variant, 850118656$zinc finger region:C2H2-type 1, 850118688$zinc finger region:C2H2-type 2, 850118711$zinc finger region:C2H2-type 3]
LATS, large tumor suppressor, homolog 1 (Drosophila),INTERPRO[450000382$IPR000449:Ubiquitin-associated/translation elongation factor EF1B, N-terminal, 450000618$IPR000719:Protein kinase, core, 450000836$IPR000961:AGC-kinase, C-terminal, 450002035$IPR002290:Serine/threonine protein kinase, 450007563$IPR008271:Serine/threonine protein kinase, active site, 450014352$IPR015940:Ubiquitin-associated/translation elongation factor EF1B, N-terminal, eukaryote, 450015769$IPR017441:Protein kinase, ATP binding site, 450015770$IPR017442:Serine/threonine protein kinase-related, 450016207$IPR017892:Protein kinase, C-terminal]
LATS, large tumor suppressor, homolog 1 (Drosophila),PIR_SUPERFAMILY[630028471$PIRSF036980:serine/threonine protein kinase LATS]
LATS, large tumor suppressor, homolog 1 (Drosophila),SMART[760000115$SM00133:S_TK_X, 760000144$SM00165:UBA, 760000193$SM00220:S_TKc]
LATS, large tumor suppressor, homolog 1 (Drosophila),SP_PIR_KEYWORDS[790000053$alternative splicing, 790000138$atp-binding, 790000258$cell cycle, 790000260$cell division, 790000356$complete proteome, 790000407$cytoplasm, 790000410$cytoskeleton, 790000825$kinase, 790000899$magnesium, 790000937$metal-binding, 790000973$mitosis, 790001063$nucleotide-binding, 790001162$phosphoprotein, 790001212$polymorphism, 790001388$serine/threonine-protein kinase, 790001547$transferase, 790001580$tumor suppressor]
LATS, large tumor suppressor, homolog 1 (Drosophila),UP_SEQ_FEATURE[850000114$active site:Proton acceptor, 850000242$binding site:ATP, 850059840$chain:Serine/threonine-protein kinase LATS1, 850103028$domain:AGC-kinase C-terminal, 850105086$domain:Protein kinase, 850105597$domain:UBA, 850106258$modified residue, 850106259$mutagenesis site, 850106263$nucleotide phosphate-binding region:ATP, 850117295$sequence variant, 850118574$splice variant]
MAS-related GPR, member D,INTERPRO[450000240$IPR000276:7TM GPCR, rhodopsin-like, 450015778$IPR017452:GPCR, rhodopsin-like superfamily]
MAS-related GPR, member D,PIR_SUPERFAMILY[630001858$PIRSF001712:mas-related G protein-coupled receptor, 630031207$PIRSF800006:rhodopsin-like G protein-coupled receptors]
MAS-related GPR, member D,SP_PIR_KEYWORDS[790000264$cell membrane, 790000356$complete proteome, 790000575$g-protein coupled receptor, 790000616$glycoprotein, 790000919$membrane, 790001301$receptor, 790001546$transducer, 790001555$transmembrane]
MAS-related GPR, member D,UP_SEQ_FEATURE[850030539$chain:Mas-related G-protein coupled receptor member D, 850105770$glycosylation site:N-linked (GlcNAc...), 850118577$topological domain:Cytoplasmic, 850118583$topological domain:Extracellular, 850118623$transmembrane region]
MORN repeat containing 3,COG_ONTOLOGY[90000070$Function unknown]
MORN repeat containing 3,INTERPRO[450002977$IPR003409:MORN motif]
MORN repeat containing 3,SMART[760000606$SM00698:MORN]
MORN repeat containing 3,SP_PIR_KEYWORDS[790000053$alternative splicing, 790000356$complete proteome, 790001304$repeat]
MORN repeat containing 3,UP_SEQ_FEATURE[850032493$chain:MORN repeat-containing protein 3, 850116382$repeat:MORN 1, 850116384$repeat:MORN 2, 850116385$repeat:MORN 3, 850116386$repeat:MORN 4, 850116387$repeat:MORN 5, 850116388$repeat:MORN 6, 850116389$repeat:MORN 7, 850118574$splice variant]
MUS81 endonuclease homolog (S. cerevisiae),COG_ONTOLOGY[90000057$DNA replication, recombination, and repair]
MUS81 endonuclease homolog (S. cerevisiae),INTERPRO[450003148$IPR003583:Helix-hairpin-helix DNA-binding, class 1, 450005598$IPR006166:DNA repair nuclease, XPF-type/Helicase, 450009999$IPR010996:DNA-directed DNA polymerase, family X, beta-like, N-terminal]
MUS81 endonuclease homolog (S. cerevisiae),KEGG_PATHWAY[470038825$hsa03440:Homologous recombination]
MUS81 endonuclease homolog (S. cerevisiae),SMART[760000249$SM00278:HhH1]
MUS81 endonuclease homolog (S. cerevisiae),SP_PIR_KEYWORDS[790000002$3d-structure, 790000356$complete proteome, 790000452$DNA damage, 790000458$dna recombination, 790000459$dna repair, 790000498$Endonuclease, 790000743$hydrolase, 790000899$magnesium, 790000937$metal-binding, 790001049$nuclease, 790001065$nucleus, 790001162$phosphoprotein, 790001212$polymorphism]
MUS81 endonuclease homolog (S. cerevisiae),UP_SEQ_FEATURE[850012712$chain:Crossover junction endonuclease MUS81, 850103718$domain:ERCC4, 850105852$helix, 850106258$modified residue, 850106259$mutagenesis site, 850112129$region of interest:Interaction with BLM, 850117295$sequence variant, 850118575$strand, 850118624$turn]
MYST histone acetyltransferase (monocytic leukemia) 3,INTERPRO[450001628$IPR001841:Zinc finger, RING-type, 450001740$IPR001965:Zinc finger, PHD-type, 450002410$IPR002717:MOZ/SAS-like protein, 450005266$IPR005818:Histone H1/H5, 450010816$IPR011991:Winged helix repressor DNA-binding, 450014522$IPR016181:Acyl-CoA N-acyltransferase, 450018019$IPR019786:Zinc finger, PHD-type, conserved site, 450018020$IPR019787:Zinc finger, PHD-finger]
MYST histone acetyltransferase (monocytic leukemia) 3,SMART[760000158$SM00184:RING, 760000221$SM00249:PHD, 760000466$SM00526:H15]
MYST histone acetyltransferase (monocytic leukemia) 3,SP_PIR_KEYWORDS[790000002$3d-structure, 790000012$acetylation, 790000020$activator, 790000025$Acyltransferase, 790000311$chromatin regulator, 790000316$chromosomal rearrangement, 790000356$complete proteome, 790000937$metal-binding, 790001065$nucleus, 790001162$phosphoprotein, 790001212$polymorphism, 790001271$Proto-oncogene, 790001304$repeat, 790001307$repressor, 790001539$Transcription, 790001543$transcription regulation, 790001547$transferase, 790001648$zinc, 790001651$zinc-finger]
MYST histone acetyltransferase (monocytic leukemia) 3,UP_SEQ_FEATURE[850023869$chain:Histone acetyltransferase MYST3, 850102501$compositionally biased region:Gln/Pro-rich, 850102507$compositionally biased region:Glu-rich, 850102562$compositionally biased region:Met-rich, 850102566$compositionally biased region:Poly-Arg, 850102572$compositionally biased region:Poly-Glu, 850102577$compositionally biased region:Poly-Lys, 850102581$compositionally biased region:Poly-Ser, 850105852$helix, 850106258$modified residue, 850106259$mutagenesis site, 850110822$region of interest:Acetylcoenzyme A binding, 850111190$region of interest:Catalytic, 850112799$region of interest:Interaction with RUNX1-1, 850112800$region of interest:Interaction with RUNX1-2, 850113357$region of interest:Mediates interaction with BRPF1, required for histone H3 acetyltransferase activity, 850114232$region of interest:Required for activation of RUNX1-1, 850114233$region of interest:Required for activation of RUNX1-2, 850114436$region of interest:Required for nuclear localization, 850117294$sequence conflict, 850117295$sequence variant, 850117908$site:Breakpoint for translocation to form MYST3-ASXL2, 850117910$site:Breakpoint for translocation to form MYST3-CREBBP, 850117912$site:Breakpoint for translocation to form MYST3-EP300 and MYST3-NCOA2, 850118575$strand, 850118624$turn, 850118743$zinc finger region:C2HC-type, 850118878$zinc finger region:PHD-type 1, 850118880$zinc finger region:PHD-type 2]
N-acetylated alpha-linked acidic dipeptidase-like 1,INTERPRO[450002761$IPR003137:Protease-associated PA, 450006727$IPR007365:Transferrin receptor-like, dimerisation, 450006838$IPR007484:Peptidase M28]
N-acetylated alpha-linked acidic dipeptidase-like 1,PIR_SUPERFAMILY[630002664$PIRSF002548:transferrin receptor]
N-acetylated alpha-linked acidic dipeptidase-like 1,SP_PIR_KEYWORDS[790000053$alternative splicing, 790000242$carboxypeptidase, 790000264$cell membrane, 790000356$complete proteome, 790000438$dipeptidase, 790000616$glycoprotein, 790000743$hydrolase, 790000919$membrane, 790000937$metal-binding, 790000941$metalloprotease, 790000993$multifunctional enzyme, 790001212$polymorphism, 790001252$Protease, 790001409$Signal-anchor, 790001555$transmembrane, 790001648$zinc]
N-acetylated alpha-linked acidic dipeptidase-like 1,UP_SEQ_FEATURE[850000011$active site:Charge relay system, 850000096$active site:Nucleophile; for NAALADase activity, 850033172$chain:N-acetylated-alpha-linked acidic dipeptidase-like protein, 850105770$glycosylation site:N-linked (GlcNAc...), 850106219$metal ion-binding site:Zinc 1, 850106226$metal ion-binding site:Zinc 2, 850113538$region of interest:NAALADase, 850117294$sequence conflict, 850117295$sequence variant, 850118574$splice variant, 850118577$topological domain:Cytoplasmic, 850118583$topological domain:Extracellular, 850118623$transmembrane region]
N-acylethanolamine acid amidase,INTERPRO[450002816$IPR003199:Choloylglycine hydrolase, 450015019$IPR016699:Acid ceramidase-like]
N-acylethanolamine acid amidase,PIR_SUPERFAMILY[630014326$PIRSF017632:acid ceramidase, 630014327$PIRSF017632:Acid_ceramidase-like]
N-acylethanolamine acid amidase,SP_PIR_KEYWORDS[790000053$alternative splicing, 790000356$complete proteome, 790000616$glycoprotein, 790000743$hydrolase, 790000897$lysosome, 790001212$polymorphism, 790001405$signal]
N-acylethanolamine acid amidase,UP_SEQ_FEATURE[850033249$chain:N-acylethanolamine-hydrolyzing acid amidase, 850105770$glycosylation site:N-linked (GlcNAc...), 850117294$sequence conflict, 850117295$sequence variant, 850117814$signal peptide, 850118574$splice variant]
N-methylpurine-DNA glycosylase,INTERPRO[450002797$IPR003180:Methylpurine-DNA glycosylase (MPG)]
N-methylpurine-DNA glycosylase,KEGG_PATHWAY[470038822$hsa03410:Base excision repair]
N-methylpurine-DNA glycosylase,PIR_SUPERFAMILY[630029368$PIRSF037794:DNA-3-methyladenine glycosylase]
N-methylpurine-DNA glycosylase,SP_PIR_KEYWORDS[790000002$3d-structure, 790000053$alternative splicing, 790000356$complete proteome, 790000452$DNA damage, 790000459$dna repair, 790000617$glycosidase, 790000743$hydrolase, 790001065$nucleus, 790001162$phosphoprotein, 790001212$polymorphism]
N-methylpurine-DNA glycosylase,UP_SEQ_FEATURE[850015879$chain:DNA-3-methyladenine glycosylase, 850105852$helix, 850106258$modified residue, 850117294$sequence conflict, 850117295$sequence variant, 850118574$splice variant, 850118575$strand, 850118624$turn]
NHL repeat containing 1,INTERPRO[450001109$IPR001258:NHL repeat, 450001628$IPR001841:Zinc finger, RING-type, 450010012$IPR011042:Six-bladed beta-propeller, TolB-like, 450011685$IPR013017:NHL repeat, subgroup, 450016222$IPR017907:Zinc finger, RING-type, conserved site]
NHL repeat containing 1,KEGG_PATHWAY[470038837$hsa04120:Ubiquitin mediated proteolysis]
NHL repeat containing 1,OMIM_DISEASE[520001756$Epilepsy, myoclonic, Lafora type, 520001766$Epilepsy, progressive myoclonic 2B]
NHL repeat containing 1,SMART[760000158$SM00184:RING]
NHL repeat containing 1,SP_PIR_KEYWORDS[790000356$complete proteome, 790000446$disease mutation, 790000499$endoplasmic reticulum, 790000509$epilepsy, 790000937$metal-binding, 790001065$nucleus, 790001212$polymorphism, 790001304$repeat, 790001648$zinc, 790001651$zinc-finger]
NHL repeat containing 1,UP_SEQ_FEATURE[850034202$chain:NHL repeat-containing protein 1, 850116579$repeat:NHL 1, 850116580$repeat:NHL 2, 850116581$repeat:NHL 3, 850116582$repeat:NHL 4, 850116583$repeat:NHL 5, 850116584$repeat:NHL 6, 850117295$sequence variant, 850118911$zinc finger region:RING-type]
NLR family, pyrin domain containing 3,INTERPRO[450001429$IPR001611:Leucine-rich repeat, 450003152$IPR003590:Leucine-rich repeat, ribonuclease inhibitor subtype, 450003539$IPR004020:Pyrin, 450006487$IPR007111:NACHT nucleoside triphosphatase, 450010009$IPR011029:DEATH-like]
NLR family, pyrin domain containing 3,KEGG_PATHWAY[470038863$hsa04621:NOD-like receptor signaling pathway]
NLR family, pyrin domain containing 3,OMIM_DISEASE[520001046$CINCA syndrome, 520001074$Cold-induced autoinflammatory syndrome, familial, 520003373$Muckle-Wells syndrome]
NLR family, pyrin domain containing 3,PIR_SUPERFAMILY[630029074$PIRSF037494:NALP protein]
NLR family, pyrin domain containing 3,SMART[760000332$SM00368:LRR_RI]
NLR family, pyrin domain containing 3,SP_PIR_KEYWORDS[790000053$alternative splicing, 790000078$amyloidosis, 790000109$Apoptosis, 790000138$atp-binding, 790000356$complete proteome, 790000407$cytoplasm, 790000415$deafness, 790000446$disease mutation, 790000853$leucine-rich repeat, 790001063$nucleotide-binding, 790001301$receptor, 790001304$repeat]
NLR family, pyrin domain containing 3,UP_SEQ_FEATURE[850033387$chain:NACHT, LRR and PYD domains-containing protein 3, 850102572$compositionally biased region:Poly-Glu, 850103482$domain:DAPIN, 850104825$domain:NACHT, 850106263$nucleotide phosphate-binding region:ATP, 850116308$repeat:LRR 1, 850116319$repeat:LRR 2, 850116330$repeat:LRR 3, 850116340$repeat:LRR 4, 850116341$repeat:LRR 5, 850116342$repeat:LRR 6, 850116343$repeat:LRR 7, 850117294$sequence conflict, 850117295$sequence variant, 850118574$splice variant]
PCTAIRE protein kinase 3,INTERPRO[450000618$IPR000719:Protein kinase, core, 450002035$IPR002290:Serine/threonine protein kinase, 450007563$IPR008271:Serine/threonine protein kinase, active site, 450009944$IPR010916:TonB box, conserved site, 450015769$IPR017441:Protein kinase, ATP binding site, 450015770$IPR017442:Serine/threonine protein kinase-related]
PCTAIRE protein kinase 3,SMART[760000193$SM00220:S_TKc]
PCTAIRE protein kinase 3,SP_PIR_KEYWORDS[790000053$alternative splicing, 790000134$ATP, 790000138$atp-binding, 790000356$complete proteome, 790000825$kinase, 790001063$nucleotide-binding, 790001162$phosphoprotein, 790001168$phosphotransferase, 790001212$polymorphism, 790001388$serine/threonine-protein kinase, 790001390$serine/threonine-specific protein kinase, 790001547$transferase]
PCTAIRE protein kinase 3,UP_SEQ_FEATURE[850000114$active site:Proton acceptor, 850000242$binding site:ATP, 850010438$chain:Cell division protein kinase 18, 850105086$domain:Protein kinase, 850106258$modified residue, 850106263$nucleotide phosphate-binding region:ATP, 850117294$sequence conflict, 850117295$sequence variant, 850118574$splice variant]
PRP18 pre-mRNA processing factor 18 homolog (S. cerevisiae),INTERPRO[450003194$IPR003648:Splicing factor motif, 450003613$IPR004098:Prp18, 450013355$IPR014906:Pre-mRNA processing factor 4 (PRP4) like]
PRP18 pre-mRNA processing factor 18 homolog (S. cerevisiae),KEGG_PATHWAY[470038818$hsa03040:Spliceosome]
PRP18 pre-mRNA processing factor 18 homolog (S. cerevisiae),PIR_SUPERFAMILY[630022606$PIRSF029771:pre-mRNA-splicing factor 18]
PRP18 pre-mRNA processing factor 18 homolog (S. cerevisiae),SMART[760000443$SM00500:SFM]
PRP18 pre-mRNA processing factor 18 homolog (S. cerevisiae),SP_PIR_KEYWORDS[790000002$3d-structure, 790000053$alternative splicing, 790000356$complete proteome, 790000988$mrna processing, 790000989$mrna splicing, 790001065$nucleus, 790001162$phosphoprotein, 790001433$Spliceosome]
PRP18 pre-mRNA processing factor 18 homolog (S. cerevisiae),UP_SEQ_FEATURE[850040385$chain:Pre-mRNA-splicing factor 18, 850105852$helix, 850106258$modified residue, 850118574$splice variant, 850118575$strand]
PTPN13-like, Y-linked pseudogene 4; PTPN13-like, Y-linked pseudogene 3; PTPN13-like, Y-linked; PTPN13-like, Y-linked 2,SP_PIR_KEYWORDS[790000053$alternative splicing, 790000356$complete proteome]
PTPN13-like, Y-linked pseudogene 4; PTPN13-like, Y-linked pseudogene 3; PTPN13-like, Y-linked; PTPN13-like, Y-linked 2,UP_SEQ_FEATURE[850048871$chain:PTPN13-like protein, Y-linked, 850118574$splice variant]
Ras association (RalGDS/AF-6) domain family (N-terminal) member 7,INTERPRO[450000135$IPR000159:Ras-association]
Ras association (RalGDS/AF-6) domain family (N-terminal) member 7,SMART[760000284$SM00314:RA]
Ras association (RalGDS/AF-6) domain family (N-terminal) member 7,SP_PIR_KEYWORDS[790000053$alternative splicing, 790000344$coiled coil, 790000356$complete proteome, 790001212$polymorphism]
Ras association (RalGDS/AF-6) domain family (N-terminal) member 7,UP_SEQ_FEATURE[850056680$chain:Ras association domain-containing protein 7, 850102586$compositionally biased region:Pro-rich, 850105145$domain:Ras-associating, 850117295$sequence variant, 850118574$splice variant]
SMAD family member 6,BIOCARTA[30000015$h_alkPathway:ALK in cardiac myocytes]
SMAD family member 6,INTERPRO[450000993$IPR001132:SMAD domain, Dwarfin-type, 450003179$IPR003619:MAD homology 1, Dwarfin-type, 450011686$IPR013019:MAD homology, MH1, 450012402$IPR013790:Dwarfin, 450016174$IPR017855:SMAD domain-like]
SMAD family member 6,KEGG_PATHWAY[470038850$hsa04350:TGF-beta signaling pathway]
SMAD family member 6,PIR_SUPERFAMILY[630028833$PIRSF037286:Smad protein, 630030640$PIRSF500412:inhibitory Smad protein, Smad 6/Smad 7 types]
SMAD family member 6,SMART[760000463$SM00523:DWA, 760000464$SM00524:DWB]
SMAD family member 6,SP_PIR_KEYWORDS[790000053$alternative splicing, 790000356$complete proteome, 790001065$nucleus, 790001162$phosphoprotein, 790001539$Transcription, 790001543$transcription regulation]
SMAD family member 6,UP_SEQ_FEATURE[850032508$chain:Mothers against decapentaplegic homolog 6, 850102565$compositionally biased region:Poly-Ala, 850102566$compositionally biased region:Poly-Arg, 850102573$compositionally biased region:Poly-Gly, 850102576$compositionally biased region:Poly-Leu, 850102580$compositionally biased region:Poly-Pro, 850104765$domain:MH1, 850104766$domain:MH2, 850106258$modified residue, 850106259$mutagenesis site, 850117294$sequence conflict, 850118574$splice variant]
SWI/SNF related, matrix associated, actin dependent regulator of chromatin, subfamily a, member 4,BIOCARTA[30000142$h_hSWI-SNFpathway:Chromatin Remodeling by hSWI/SNF ATP-dependent Complexes, 30000306$h_vdrPathway:Control of Gene Expression by Vitamin D Receptor]
SWI/SNF related, matrix associated, actin dependent regulator of chromatin, subfamily a, member 4,INTERPRO[450000283$IPR000330:SNF2-related, 450001324$IPR001487:Bromodomain, 450001461$IPR001650:DNA/RNA helicase, C-terminal, 450005982$IPR006562:HSA, 450005996$IPR006576:BRK domain, 450012593$IPR013999:HAS subgroup, 450012595$IPR014001:DEAD-like helicase, N-terminal, 450012606$IPR014012:Helicase/SANT-associated, DNA binding, 450012615$IPR014021:Helicase, superfamily 1 and 2, ATP-binding, 450013427$IPR014978:Glutamine-Leucine-Glutamine, QLQ, 450016644$IPR018359:Bromodomain, conserved site]
SWI/SNF related, matrix associated, actin dependent regulator of chromatin, subfamily a, member 4,PIR_SUPERFAMILY[630027745$PIRSF036309:SNF2-family ATP-dependent chromatin remodeling factor, 630031063$PIRSF500926:SWI/SNF related, matrix associated, actin dependent regulator of chromatin]
SWI/SNF related, matrix associated, actin dependent regulator of chromatin, subfamily a, member 4,SMART[760000267$SM00297:BROMO, 760000432$SM00487:DEXDc, 760000434$SM00490:HELICc, 760000510$SM00573:HSA, 760000526$SM00592:BRK]
SWI/SNF related, matrix associated, actin dependent regulator of chromatin, subfamily a, member 4,SP_PIR_KEYWORDS[790000002$3d-structure, 790000012$acetylation, 790000020$activator, 790000138$atp-binding, 790000206$bromodomain, 790000311$chromatin regulator, 790000356$complete proteome, 790000649$helicase, 790000743$hydrolase, 790001016$neurogenesis, 790001063$nucleotide-binding, 790001065$nucleus, 790001162$phosphoprotein, 790001212$polymorphism, 790001539$Transcription, 790001543$transcription regulation]
SWI/SNF related, matrix associated, actin dependent regulator of chromatin, subfamily a, member 4,UP_SEQ_FEATURE[850064930$chain:Transcription activator BRG1, 850102572$compositionally biased region:Poly-Glu, 850102577$compositionally biased region:Poly-Lys, 850103166$domain:Bromo, 850104106$domain:Helicase ATP-binding, 850104111$domain:Helicase C-terminal, 850104152$domain:HSA, 850105852$helix, 850106258$modified residue, 850106259$mutagenesis site, 850106263$nucleotide phosphate-binding region:ATP, 850113649$region of interest:Necessary for interaction with SS18L1/CREST, 850117294$sequence conflict, 850117295$sequence variant, 850117399$short sequence motif:DEGH box, 850118516$site:Required for binding to 'Lys-15'- acetylated histone 3, 850118575$strand, 850118624$turn]
TNF receptor-associated factor 3 interacting protein 1,INTERPRO[450017071$IPR018799:Microtubule/TRAF3 and DISC1 binding protein]
TNF receptor-associated factor 3 interacting protein 1,SP_PIR_KEYWORDS[790000002$3d-structure, 790000053$alternative splicing, 790000344$coiled coil, 790000356$complete proteome, 790000407$cytoplasm, 790000410$cytoskeleton, 790001162$phosphoprotein, 790001212$polymorphism]
TNF receptor-associated factor 3 interacting protein 1,UP_SEQ_FEATURE[850064875$chain:TRAF3-interacting protein 1, 850102404$compositionally biased region:Arg-rich, 850105852$helix, 850106258$modified residue, 850110809$region of interest:Abolishes microtubules-binding when missing, 850111443$region of interest:DISC1-interaction domain, 850117295$sequence variant, 850118574$splice variant, 850118624$turn]
TYRO protein tyrosine kinase binding protein,KEGG_PATHWAY[470038868$hsa04650:Natural killer cell mediated cytotoxicity]
TYRO protein tyrosine kinase binding protein,OMIM_DISEASE[520003553$Nasu-Hakola disease]
TYRO protein tyrosine kinase binding protein,SP_PIR_KEYWORDS[790000053$alternative splicing, 790000356$complete proteome, 790000447$disulfide bond, 790000919$membrane, 790001162$phosphoprotein, 790001212$polymorphism, 790001405$signal, 790001555$transmembrane]
TYRO protein tyrosine kinase binding protein,UP_SEQ_FEATURE[850067522$chain:TYRO protein tyrosine kinase-binding protein, 850106258$modified residue, 850117295$sequence variant, 850117814$signal peptide, 850118574$splice variant, 850118577$topological domain:Cytoplasmic, 850118583$topological domain:Extracellular, 850118623$transmembrane region]
UDP-glucose ceramide glucosyltransferase,INTERPRO[450001029$IPR001173:Glycosyl transferase, family 2]
UDP-glucose ceramide glucosyltransferase,KEGG_PATHWAY[470038783$hsa00600:Sphingolipid metabolism]
UDP-glucose ceramide glucosyltransferase,SP_PIR_KEYWORDS[790000356$complete proteome, 790000499$endoplasmic reticulum, 790000619$glycosyltransferase, 790000873$lipid metabolism, 790000874$lipid synthesis, 790000919$membrane, 790001428$sphingolipid metabolism, 790001547$transferase, 790001555$transmembrane]
UDP-glucose ceramide glucosyltransferase,UP_SEQ_FEATURE[850010718$chain:Ceramide glucosyltransferase, 850118423$site:May play an important role in binding to the inhibitors DEPC and PDMP, 850118590$topological domain:Lumenal, 850118623$transmembrane region]
WD repeat domain 55,INTERPRO[450001490$IPR001680:WD40 repeat, 450014355$IPR015943:WD40/YVTN repeat-like, 450015750$IPR017422:WD repeat protein 55, 450016294$IPR017986:WD40 repeat, region, 450018010$IPR019775:WD40 repeat, conserved site, 450018016$IPR019781:WD40 repeat, subgroup, 450018017$IPR019782:WD40 repeat 2]
WD repeat domain 55,PIR_SUPERFAMILY[630029784$PIRSF038169:WD repeat protein 55, 630029785$PIRSF038169:WD_repeat_p55]
WD repeat domain 55,SMART[760000289$SM00320:WD40]
WD repeat domain 55,SP_PIR_KEYWORDS[790000053$alternative splicing, 790000356$complete proteome, 790000407$cytoplasm, 790001065$nucleus, 790001162$phosphoprotein, 790001212$polymorphism, 790001304$repeat, 790001345$rrna processing, 790001638$wd repeat]
WD repeat domain 55,UP_SEQ_FEATURE[850100757$chain:WD repeat-containing protein 55, 850106258$modified residue, 850117171$repeat:WD 1, 850117182$repeat:WD 2, 850117193$repeat:WD 3, 850117195$repeat:WD 4, 850117196$repeat:WD 5, 850117197$repeat:WD 6, 850117198$repeat:WD 7, 850117295$sequence variant, 850118574$splice variant]
YY1 associated protein 1; gon-4-like (C. elegans),INTERPRO[450000876$IPR001005:SANT, DNA-binding, 450003356$IPR003822:Paired amphipathic helix, 450016195$IPR017877:MYB-like]
YY1 associated protein 1; gon-4-like (C. elegans),SMART[760000623$SM00717:SANT]
YY1 associated protein 1; gon-4-like (C. elegans),SP_PIR_KEYWORDS[790000053$alternative splicing, 790000356$complete proteome, 790000407$cytoplasm, 790000811$isopeptide bond, 790001065$nucleus, 790001162$phosphoprotein, 790001212$polymorphism, 790001304$repeat, 790001592$ubl conjugation]
YY1 associated protein 1; gon-4-like (C. elegans),UP_SEQ_FEATURE[850022263$chain:GON-4-like protein, 850101176$chain:YY1-associated protein 1, 850102458$compositionally biased region:Asp-rich, 850102507$compositionally biased region:Glu-rich, 850102577$compositionally biased region:Poly-Lys, 850102580$compositionally biased region:Poly-Pro, 850102720$cross-link:Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in ubiquitin), 850104805$domain:Myb-like, 850106258$modified residue, 850116588$repeat:PAH 1, 850116589$repeat:PAH 2, 850117294$sequence conflict, 850117295$sequence variant, 850118574$splice variant]
abhydrolase domain containing 12,INTERPRO[450000062$IPR000073:Alpha/beta hydrolase fold-1]
abhydrolase domain containing 12,SP_PIR_KEYWORDS[790000053$alternative splicing, 790000356$complete proteome, 790000616$glycoprotein, 790000743$hydrolase, 790000919$membrane, 790001212$polymorphism, 790001555$transmembrane]
abhydrolase domain containing 12,UP_SEQ_FEATURE[850000011$active site:Charge relay system, 850032401$chain:Monoacylglycerol lipase ABHD12, 850102565$compositionally biased region:Poly-Ala, 850102581$compositionally biased region:Poly-Ser, 850117294$sequence conflict, 850117295$sequence variant, 850118574$splice variant, 850118577$topological domain:Cytoplasmic, 850118583$topological domain:Extracellular, 850118623$transmembrane region]
adaptor-related protein complex 3, delta 1 subunit,COG_ONTOLOGY[90000079$Intracellular trafficking and secretion]
adaptor-related protein complex 3, delta 1 subunit,INTERPRO[450002270$IPR002553:Clathrin/coatomer adaptor, adaptin-like, N-terminal, 450009533$IPR010474:Bovine leukaemia virus receptor, 450010814$IPR011989:Armadillo-like helical, 450015425$IPR017105:Adaptor protein complex AP-3, delta subunit]
adaptor-related protein complex 3, delta 1 subunit,KEGG_PATHWAY[470038840$hsa04142:Lysosome]
adaptor-related protein complex 3, delta 1 subunit,PIR_SUPERFAMILY[630028593$PIRSF037092:adaptor protein complex AP-3, delta subunit, 630028594$PIRSF037092:AP3_complex_delta]
adaptor-related protein complex 3, delta 1 subunit,SP_PIR_KEYWORDS[790000053$alternative splicing, 790000356$complete proteome, 790000407$cytoplasm, 790000624$golgi apparatus, 790000919$membrane, 790001162$phosphoprotein, 790001212$polymorphism, 790001266$protein transport, 790001558$transport]
adaptor-related protein complex 3, delta 1 subunit,UP_SEQ_FEATURE[850005731$chain:AP-3 complex subunit delta-1, 850106258$modified residue, 850117294$sequence conflict, 850117295$sequence variant, 850118574$splice variant]
adducin 1 (alpha),BIOCARTA[30000223$h_PDZsPathway:Synaptic Proteins at the Synaptic Junction]
adducin 1 (alpha),INTERPRO[450001148$IPR001303:Class II aldolase/adducin, N-terminal]
adducin 1 (alpha),OMIM_DISEASE[520002478$Hypertension, essential, salt-sensitive]
adducin 1 (alpha),SP_PIR_KEYWORDS[790000012$acetylation, 790000019$actin-binding, 790000053$alternative splicing, 790000218$calmodulin-binding, 790000264$cell membrane, 790000356$complete proteome, 790000407$cytoplasm, 790000410$cytoskeleton, 790000445$direct protein sequencing, 790000919$membrane, 790001162$phosphoprotein, 790001212$polymorphism]
adducin 1 (alpha),UP_SEQ_FEATURE[850004690$chain:Alpha-adducin, 850106258$modified residue, 850106259$mutagenesis site, 850112141$region of interest:Interaction with calmodulin, 850117294$sequence conflict, 850117295$sequence variant, 850118574$splice variant]
ankyrin repeat domain 40,INTERPRO[450001870$IPR002110:Ankyrin]
ankyrin repeat domain 40,PIR_SUPERFAMILY[630028847$PIRSF037301:uncharacterized protein with ankyrin repeat domain, ANKRD40 type]
ankyrin repeat domain 40,SMART[760000220$SM00248:ANK]
ankyrin repeat domain 40,SP_PIR_KEYWORDS[790000012$acetylation, 790000086$ank repeat, 790000356$complete proteome, 790000445$direct protein sequencing, 790001304$repeat]
ankyrin repeat domain 40,UP_SEQ_FEATURE[850005399$chain:Ankyrin repeat domain-containing protein 40, 850102568$compositionally biased region:Poly-Asp, 850102586$compositionally biased region:Pro-rich, 850106258$modified residue, 850115632$repeat:ANK 1, 850115644$repeat:ANK 2, 850117294$sequence conflict]
apoptosis-associated tyrosine kinase,INTERPRO[450000618$IPR000719:Protein kinase, core, 450001096$IPR001245:Tyrosine protein kinase, 450007559$IPR008266:Tyrosine protein kinase, active site, 450015769$IPR017441:Protein kinase, ATP binding site]
apoptosis-associated tyrosine kinase,SMART[760000192$SM00219:TyrKc]
apoptosis-associated tyrosine kinase,SP_PIR_KEYWORDS[790000053$alternative splicing, 790000138$atp-binding, 790000356$complete proteome, 790000407$cytoplasm, 790000825$kinase, 790000919$membrane, 790001063$nucleotide-binding, 790001162$phosphoprotein, 790001212$polymorphism, 790001388$serine/threonine-protein kinase, 790001547$transferase, 790001555$transmembrane]
apoptosis-associated tyrosine kinase,UP_SEQ_FEATURE[850000114$active site:Proton acceptor, 850000242$binding site:ATP, 850059842$chain:Serine/threonine-protein kinase LMTK1, 850102572$compositionally biased region:Poly-Glu, 850102573$compositionally biased region:Poly-Gly, 850102581$compositionally biased region:Poly-Ser, 850102586$compositionally biased region:Pro-rich, 850105086$domain:Protein kinase, 850106263$nucleotide phosphate-binding region:ATP, 850117294$sequence conflict, 850117295$sequence variant, 850118574$splice variant, 850118623$transmembrane region]
axin 1,BIOCARTA[30000015$h_alkPathway:ALK in cardiac myocytes, 30000131$h_gsk3Pathway:Inactivation of Gsk3 by AKT causes accumulation of b-catenin in Alveolar Macrophages, 30000227$h_pitx2Pathway:Multi-step Regulation of Transcription by Pitx2, 30000240$h_ps1Pathway:Presenilin action in Notch and Wnt signaling, 30000313$h_wntPathway:WNT Signaling Pathway]
axin 1,INTERPRO[450000294$IPR000342:Regulator of G protein signalling, 450001015$IPR001158:DIX, 450013385$IPR014936:Axin beta-catenin binding]
axin 1,KEGG_PATHWAY[470038846$hsa04310:Wnt signaling pathway, 470038899$hsa05200:Pathways in cancer, 470038900$hsa05210:Colorectal cancer, 470038903$hsa05213:Endometrial cancer, 470038907$hsa05217:Basal cell carcinoma]
axin 1,OMIM_DISEASE[520000875$Caudal duplication anomaly, 520002293$Hepatocellular carcinoma, somatic]
axin 1,PIR_SUPERFAMILY[630029842$PIRSF038234:axis inhibition protein (axin)]
axin 1,SMART[760000014$SM00021:DAX, 760000285$SM00315:RGS]
axin 1,SP_PIR_KEYWORDS[790000002$3d-structure, 790000053$alternative splicing, 790000109$Apoptosis, 790000356$complete proteome, 790000407$cytoplasm, 790000428$developmental protein, 790000446$disease mutation, 790001162$phosphoprotein, 790001580$tumor suppressor, 790001642$wnt signaling pathway]
axin 1,UP_SEQ_FEATURE[850007014$chain:Axin-1, 850103527$domain:DIX, 850105178$domain:RGS, 850105852$helix, 850106258$modified residue, 850112126$region of interest:Interaction with beta-catenin, 850112379$region of interest:Interaction with GSK3B, 850112396$region of interest:Interaction with HIPK2, 850112787$region of interest:Interaction with RNF111, 850112962$region of interest:Interaction with TP53, 850117294$sequence conflict, 850117295$sequence variant, 850118574$splice variant, 850118624$turn]
basigin (Ok blood group),INTERPRO[450003159$IPR003598:Immunoglobulin subtype 2, 450003160$IPR003599:Immunoglobulin subtype, 450006486$IPR007110:Immunoglobulin-like, 450008271$IPR009151:Basigin, 450011788$IPR013151:Immunoglobulin, 450012396$IPR013783:Immunoglobulin-like fold]
basigin (Ok blood group),OMIM_DISEASE[520000610$Blood group, OK]
basigin (Ok blood group),SMART[760000356$SM00408:IGc2, 760000357$SM00409:IG]
basigin (Ok blood group),SP_PIR_KEYWORDS[790000002$3d-structure, 790000053$alternative splicing, 790000194$blood group antigen, 790000264$cell membrane, 790000356$complete proteome, 790000445$direct protein sequencing, 790000447$disulfide bond, 790000616$glycoprotein, 790000768$Immunoglobulin domain, 790000848$Lectin, 790000907$mannose-binding, 790000919$membrane, 790001162$phosphoprotein, 790001212$polymorphism, 790001405$signal, 790001555$transmembrane]
basigin (Ok blood group),UP_SEQ_FEATURE[850007403$chain:Basigin, 850102568$compositionally biased region:Poly-Asp, 850102883$disulfide bond, 850104355$domain:Ig-like C2-type, 850104407$domain:Ig-like V-type, 850105770$glycosylation site:N-linked (GlcNAc...), 850105852$helix, 850106258$modified residue, 850117294$sequence conflict, 850117295$sequence variant, 850117814$signal peptide, 850118574$splice variant, 850118575$strand, 850118577$topological domain:Cytoplasmic, 850118583$topological domain:Extracellular, 850118623$transmembrane region, 850118624$turn]
beta-1,3-glucuronyltransferase 3 (glucuronosyltransferase I),INTERPRO[450004496$IPR005027:Glycosyl transferase, family 43]
beta-1,3-glucuronyltransferase 3 (glucuronosyltransferase I),KEGG_PATHWAY[470038772$hsa00532:Chondroitin sulfate biosynthesis, 470038774$hsa00534:Heparan sulfate biosynthesis]
beta-1,3-glucuronyltransferase 3 (glucuronosyltransferase I),PIR_SUPERFAMILY[630013184$PIRSF016413:beta-1,3-glucuronyltransferase]
beta-1,3-glucuronyltransferase 3 (glucuronosyltransferase I),SP_PIR_KEYWORDS[790000002$3d-structure, 790000356$complete proteome, 790000447$disulfide bond, 790000616$glycoprotein, 790000624$golgi apparatus, 790000906$manganese, 790000919$membrane, 790000937$metal-binding, 790001409$Signal-anchor, 790001547$transferase, 790001555$transmembrane]
beta-1,3-glucuronyltransferase 3 (glucuronosyltransferase I),UP_SEQ_FEATURE[850000114$active site:Proton acceptor, 850020427$chain:Galactosylgalactosylxylosylprotein 3- beta-glucuronosyltransferase 3, 850102883$disulfide bond, 850105770$glycosylation site:N-linked (GlcNAc...), 850105852$helix, 850106173$metal ion-binding site:Manganese, 850106259$mutagenesis site, 850117294$sequence conflict, 850118575$strand, 850118577$topological domain:Cytoplasmic, 850118590$topological domain:Lumenal, 850118623$transmembrane region, 850118624$turn]
bone morphogenetic protein 1,INTERPRO[450000128$IPR000152:EGF-type aspartate/asparagine hydroxylation conserved site, 450000637$IPR000742:EGF-like, type 3, 450000750$IPR000859:CUB, 450001339$IPR001506:Peptidase M12A, astacin, 450001663$IPR001881:EGF-like calcium-binding, 450005465$IPR006025:Peptidase M, neutral zinc metallopeptidases, zinc-binding site, 450005466$IPR006026:Peptidase, metallopeptidases, 450005635$IPR006209:EGF, 450011699$IPR013032:EGF-like region, conserved site, 450011735$IPR013091:EGF calcium-binding, 450013888$IPR015446:Bone morphogenetic protein 1/tolloid-like protein, 450016397$IPR018097:EGF-like calcium-binding, conserved site]
bone morphogenetic protein 1,PIR_SUPERFAMILY[630001339$PIRSF001199:BMP_1/tolloid-like]
bone morphogenetic protein 1,SMART[760000034$SM00042:CUB, 760000153$SM00179:EGF_CA, 760000207$SM00235:ZnMc]
bone morphogenetic protein 1,SP_PIR_KEYWORDS[790000002$3d-structure, 790000053$alternative splicing, 790000211$calcium, 790000307$Chondrogenesis, 790000329$cleavage on pair of basic residues, 790000356$complete proteome, 790000402$cytokine, 790000428$developmental protein, 790000434$differentiation, 790000447$disulfide bond, 790000481$egf-like domain, 790000616$glycoprotein, 790000632$growth factor, 790000743$hydrolase, 790000937$metal-binding, 790000941$metalloprotease, 790001083$osteogenesis, 790001212$polymorphism, 790001252$Protease, 790001304$repeat, 790001405$signal, 790001648$zinc, 790001652$zymogen]
bone morphogenetic protein 1,UP_SEQ_FEATURE[850008216$chain:Bone morphogenetic protein 1, 850102883$disulfide bond, 850103433$domain:CUB 1, 850103444$domain:CUB 2, 850103453$domain:CUB 3, 850103454$domain:CUB 4, 850103455$domain:CUB 5, 850103620$domain:EGF-like 1; calcium-binding, 850103644$domain:EGF-like 2; calcium-binding, 850105770$glycosylation site:N-linked (GlcNAc...), 850105852$helix, 850106244$metal ion-binding site:Zinc; catalytic, 850113432$region of interest:Metalloprotease, 850117294$sequence conflict, 850117295$sequence variant, 850117814$signal peptide, 850118574$splice variant, 850118575$strand, 850118624$turn]
bromodomain containing 2,INTERPRO[450001324$IPR001487:Bromodomain, 450016644$IPR018359:Bromodomain, conserved site]
bromodomain containing 2,SMART[760000267$SM00297:BROMO]
bromodomain containing 2,SP_PIR_KEYWORDS[790000002$3d-structure, 790000012$acetylation, 790000053$alternative splicing, 790000206$bromodomain, 790000356$complete proteome, 790000473$duplication, 790001065$nucleus, 790001162$phosphoprotein, 790001212$polymorphism, 790001304$repeat]
bromodomain containing 2,UP_SEQ_FEATURE[850008426$chain:Bromodomain-containing protein 2, 850102435$compositionally biased region:Arg/Lys-rich (highly basic), 850102516$compositionally biased region:Glu/Ser-rich, 850102572$compositionally biased region:Poly-Glu, 850102577$compositionally biased region:Poly-Lys, 850102580$compositionally biased region:Poly-Pro, 850102581$compositionally biased region:Poly-Ser, 850102597$compositionally biased region:Ser-rich, 850103167$domain:Bromo 1, 850103168$domain:Bromo 2, 850103720$domain:ET, 850105852$helix, 850106258$modified residue, 850106259$mutagenesis site, 850117295$sequence variant, 850117610$short sequence motif:Nuclear localization signal, 850118574$splice variant, 850118624$turn]
bruno-like 4, RNA binding protein (Drosophila),INTERPRO[450000430$IPR000504:RNA recognition motif, RNP-1, 450011357$IPR012677:Nucleotide-binding, alpha-beta plait, 450014322$IPR015903:Ribonucleoprotein, BRUNO-like]
bruno-like 4, RNA binding protein (Drosophila),OMIM_DISEASE[520005091$Whole genome association study identifies polymorphisms associated with QT prolongation during iloperidone treatment of schizophrenia]
bruno-like 4, RNA binding protein (Drosophila),SMART[760000328$SM00360:RRM]
bruno-like 4, RNA binding protein (Drosophila),SP_PIR_KEYWORDS[790000002$3d-structure, 790000053$alternative splicing, 790000356$complete proteome, 790000407$cytoplasm, 790001065$nucleus, 790001212$polymorphism, 790001304$repeat, 790001339$rna-binding]
bruno-like 4, RNA binding protein (Drosophila),UP_SEQ_FEATURE[850012827$chain:CUG-BP- and ETR-3-like factor 4, 850102378$compositionally biased region:Ala-rich, 850105212$domain:RRM 1, 850105213$domain:RRM 2, 850105214$domain:RRM 3, 850105852$helix, 850113711$region of interest:Necessary for TNNT2 exon 5 inclusion, 850114811$region of interest:Sufficient for RNA-binding and MSE- dependent splicing activity, 850117294$sequence conflict, 850117295$sequence variant, 850118574$splice variant, 850118575$strand, 850118624$turn]
calcineurin-like phosphoesterase domain containing 1,INTERPRO[450004322$IPR004843:Metallophosphoesterase]
calcineurin-like phosphoesterase domain containing 1,SP_PIR_KEYWORDS[790000053$alternative splicing, 790000356$complete proteome, 790000743$hydrolase, 790000937$metal-binding, 790001212$polymorphism]
calcineurin-like phosphoesterase domain containing 1,UP_SEQ_FEATURE[850008911$chain:Calcineurin-like phosphoesterase domain- containing protein 1, 850105987$metal ion-binding site:Divalent metal cation 1, 850105990$metal ion-binding site:Divalent metal cation 2, 850117294$sequence conflict, 850117295$sequence variant, 850118574$splice variant]
calcium/calmodulin-dependent protein kinase kinase 1, alpha,INTERPRO[450000618$IPR000719:Protein kinase, core, 450002035$IPR002290:Serine/threonine protein kinase, 450007563$IPR008271:Serine/threonine protein kinase, active site, 450015769$IPR017441:Protein kinase, ATP binding site, 450015770$IPR017442:Serine/threonine protein kinase-related]
calcium/calmodulin-dependent protein kinase kinase 1, alpha,KEGG_PATHWAY[470038886$hsa04920:Adipocytokine signaling pathway]
calcium/calmodulin-dependent protein kinase kinase 1, alpha,SMART[760000193$SM00220:S_TKc]
calcium/calmodulin-dependent protein kinase kinase 1, alpha,SP_PIR_KEYWORDS[790000053$alternative splicing, 790000138$atp-binding, 790000218$calmodulin-binding, 790000356$complete proteome, 790000407$cytoplasm, 790000825$kinase, 790001063$nucleotide-binding, 790001065$nucleus, 790001162$phosphoprotein, 790001212$polymorphism, 790001388$serine/threonine-protein kinase, 790001547$transferase]
calcium/calmodulin-dependent protein kinase kinase 1, alpha,UP_SEQ_FEATURE[850000114$active site:Proton acceptor, 850000242$binding site:ATP, 850009078$chain:Calcium/calmodulin-dependent protein kinase kinase 1, 850105086$domain:Protein kinase, 850106258$modified residue, 850106263$nucleotide phosphate-binding region:ATP, 850110972$region of interest:Autoinhibitory domain, 850111164$region of interest:Calmodulin-binding, 850114558$region of interest:RP domain, 850117295$sequence variant, 850118574$splice variant]
cardiotrophin 1,BIOCARTA[30000199$h_nfatPathway:NFAT and Hypertrophy of the heart (Transcription in the broken heart)]
cardiotrophin 1,INTERPRO[450009726$IPR010681:Plethodontid receptivity factor PRF]
cardiotrophin 1,KEGG_PATHWAY[470038830$hsa04060:Cytokine-cytokine receptor interaction, 470038866$hsa04630:Jak-STAT signaling pathway]
cardiotrophin 1,PIR_SUPERFAMILY[630013402$PIRSF016617:PIRSF016617]
cardiotrophin 1,SP_PIR_KEYWORDS[790000356$complete proteome, 790000402$cytokine, 790001212$polymorphism, 790001363$Secreted]
cardiotrophin 1,UP_SEQ_FEATURE[850009719$chain:Cardiotrophin-1, 850117295$sequence variant]
casein kinase 1, alpha 1,BIOCARTA[30000199$h_nfatPathway:NFAT and Hypertrophy of the heart (Transcription in the broken heart), 30000214$h_p35alzheimersPathway:Deregulation of CDK5 in Alzheimers Disease, 30000216$h_p53hypoxiaPathway:Hypoxia and p53 in the Cardiovascular system, 30000313$h_wntPathway:WNT Signaling Pathway]
casein kinase 1, alpha 1,INTERPRO[450000618$IPR000719:Protein kinase, core, 450007563$IPR008271:Serine/threonine protein kinase, active site, 450015769$IPR017441:Protein kinase, ATP binding site, 450015770$IPR017442:Serine/threonine protein kinase-related]
casein kinase 1, alpha 1,KEGG_PATHWAY[470038846$hsa04310:Wnt signaling pathway, 470038849$hsa04340:Hedgehog signaling pathway]
casein kinase 1, alpha 1,PIR_SUPERFAMILY[630000671$PIRSF000564:kinase-related transforming protein, 630031202$PIRSF501113:casein kinase 1]
casein kinase 1, alpha 1,SP_PIR_KEYWORDS[790000012$acetylation, 790000053$alternative splicing, 790000138$atp-binding, 790000258$cell cycle, 790000260$cell division, 790000356$complete proteome, 790000407$cytoplasm, 790000410$cytoskeleton, 790000445$direct protein sequencing, 790000825$kinase, 790000827$kinetochore, 790000973$mitosis, 790001063$nucleotide-binding, 790001162$phosphoprotein, 790001212$polymorphism, 790001388$serine/threonine-protein kinase, 790001547$transferase, 790001642$wnt signaling pathway]
casein kinase 1, alpha 1,UP_SEQ_FEATURE[850000114$active site:Proton acceptor, 850000242$binding site:ATP, 850009774$chain:Casein kinase I isoform alpha, 850105086$domain:Protein kinase, 850106258$modified residue, 850106263$nucleotide phosphate-binding region:ATP, 850117294$sequence conflict, 850117295$sequence variant, 850118574$splice variant]
casein kinase 1, delta,BIOCARTA[30000065$h_ck1Pathway:Regulation of ck1/cdk5 by type 1 glutamate receptors]
casein kinase 1, delta,INTERPRO[450000618$IPR000719:Protein kinase, core, 450007563$IPR008271:Serine/threonine protein kinase, active site, 450015769$IPR017441:Protein kinase, ATP binding site, 450015770$IPR017442:Serine/threonine protein kinase-related]
casein kinase 1, delta,KEGG_PATHWAY[470038849$hsa04340:Hedgehog signaling pathway, 470038858$hsa04540:Gap junction, 470038875$hsa04710:Circadian rhythm]
casein kinase 1, delta,PIR_SUPERFAMILY[630000671$PIRSF000564:kinase-related transforming protein, 630031202$PIRSF501113:casein kinase 1]
casein kinase 1, delta,SP_PIR_KEYWORDS[790000053$alternative splicing, 790000138$atp-binding, 790000356$complete proteome, 790000407$cytoplasm, 790000446$disease mutation, 790000825$kinase, 790001063$nucleotide-binding, 790001162$phosphoprotein, 790001212$polymorphism, 790001388$serine/threonine-protein kinase, 790001547$transferase, 790001642$wnt signaling pathway]
casein kinase 1, delta,UP_SEQ_FEATURE[850000114$active site:Proton acceptor, 850000242$binding site:ATP, 850009777$chain:Casein kinase I isoform delta, 850105086$domain:Protein kinase, 850106258$modified residue, 850106263$nucleotide phosphate-binding region:ATP, 850110970$region of interest:Autoinhibitory, 850117294$sequence conflict, 850117295$sequence variant, 850118574$splice variant]
caspase recruitment domain family, member 11,COG_ONTOLOGY[90000025$Cell division and chromosome partitioning]
caspase recruitment domain family, member 11,INTERPRO[450001158$IPR001315:Caspase Recruitment, 450001316$IPR001478:PDZ/DHR/GLGF, 450007477$IPR008144:Guanylate kinase]
caspase recruitment domain family, member 11,KEGG_PATHWAY[470038869$hsa04660:T cell receptor signaling pathway, 470038870$hsa04662:B cell receptor signaling pathway]
caspase recruitment domain family, member 11,PIR_SUPERFAMILY[630029128$PIRSF037539:PIRSF037539]
caspase recruitment domain family, member 11,SMART[760000101$SM00114:CARD, 760000200$SM00228:PDZ]
caspase recruitment domain family, member 11,SP_PIR_KEYWORDS[790000344$coiled coil, 790000356$complete proteome, 790000407$cytoplasm, 790000919$membrane, 790001162$phosphoprotein, 790001212$polymorphism]
caspase recruitment domain family, member 11,UP_SEQ_FEATURE[850009805$chain:Caspase recruitment domain-containing protein 11, 850103287$domain:CARD, 850104093$domain:Guanylate kinase-like, 850104918$domain:PDZ, 850106258$modified residue, 850117294$sequence conflict, 850117295$sequence variant]
cell division cycle 2-like 5 (cholinesterase-related cell division controller),INTERPRO[450000618$IPR000719:Protein kinase, core, 450002035$IPR002290:Serine/threonine protein kinase, 450007563$IPR008271:Serine/threonine protein kinase, active site, 450015769$IPR017441:Protein kinase, ATP binding site, 450015770$IPR017442:Serine/threonine protein kinase-related]
cell division cycle 2-like 5 (cholinesterase-related cell division controller),SMART[760000193$SM00220:S_TKc]
cell division cycle 2-like 5 (cholinesterase-related cell division controller),SP_PIR_KEYWORDS[790000012$acetylation, 790000053$alternative splicing, 790000134$ATP, 790000138$atp-binding, 790000259$cell cycle control, 790000260$cell division, 790000356$complete proteome, 790000825$kinase, 790000973$mitosis, 790001063$nucleotide-binding, 790001162$phosphoprotein, 790001168$phosphotransferase, 790001212$polymorphism, 790001388$serine/threonine-protein kinase, 790001390$serine/threonine-specific protein kinase, 790001547$transferase]
cell division cycle 2-like 5 (cholinesterase-related cell division controller),UP_SEQ_FEATURE[850000114$active site:Proton acceptor, 850000242$binding site:ATP, 850010433$chain:Cell division protein kinase 13, 850105086$domain:Protein kinase, 850106258$modified residue, 850106263$nucleotide phosphate-binding region:ATP, 850117294$sequence conflict, 850117295$sequence variant, 850118574$splice variant]
centrobin, centrosomal BRCA2 interacting protein,SP_PIR_KEYWORDS[790000053$alternative splicing, 790000258$cell cycle, 790000260$cell division, 790000344$coiled coil, 790000356$complete proteome, 790000407$cytoplasm, 790000410$cytoskeleton, 790001162$phosphoprotein, 790001212$polymorphism]
centrobin, centrosomal BRCA2 interacting protein,UP_SEQ_FEATURE[850010652$chain:Centrobin, 850102586$compositionally biased region:Pro-rich, 850106258$modified residue, 850114271$region of interest:Required for centrosome localization, 850117294$sequence conflict, 850117295$sequence variant, 850118574$splice variant]
cholinergic receptor, nicotinic, beta 4,INTERPRO[450002127$IPR002394:Nicotinic acetylcholine receptor, N-terminal, 450005469$IPR006029:Neurotransmitter-gated ion-channel transmembrane region, 450005627$IPR006201:Neurotransmitter-gated ion-channel, 450005628$IPR006202:Neurotransmitter-gated ion-channel ligand-binding, 450016308$IPR018000:Neurotransmitter-gated ion-channel, conserved site]
cholinergic receptor, nicotinic, beta 4,OMIM_DISEASE[520000080$A susceptibility locus for lung cancer maps to nicotinic acteylcholine receptor subunit genes on 15q25, 520000081$A variant associated with nicotine dependence, lung cancer and peripheral arterial disease, 520001859$Familial Aggregation of Common Sequence Variants on 15q24-25.1 in Lung Cancer]
cholinergic receptor, nicotinic, beta 4,PIR_SUPERFAMILY[630002560$PIRSF002443:acetylcholine receptor]
cholinergic receptor, nicotinic, beta 4,SP_PIR_KEYWORDS[790000002$3d-structure, 790000263$cell junction, 790000264$cell membrane, 790000356$complete proteome, 790000447$disulfide bond, 790000616$glycoprotein, 790000798$ion transport, 790000799$ionic channel, 790000919$membrane, 790001026$neurotransmitter receptor, 790001212$polymorphism, 790001223$postsynaptic cell membrane, 790001405$signal, 790001475$synapse, 790001555$transmembrane, 790001556$transmembrane protein, 790001558$transport]
cholinergic receptor, nicotinic, beta 4,UP_SEQ_FEATURE[850034033$chain:Neuronal acetylcholine receptor subunit beta-4, 850102883$disulfide bond, 850105770$glycosylation site:N-linked (GlcNAc...), 850117294$sequence conflict, 850117295$sequence variant, 850117814$signal peptide, 850118577$topological domain:Cytoplasmic, 850118583$topological domain:Extracellular, 850118623$transmembrane region]
chromatin accessibility complex 1,INTERPRO[450003481$IPR003958:Transcription factor CBF/NF-Y/archaeal histone, 450008207$IPR009072:Histone-fold]
chromatin accessibility complex 1,SP_PIR_KEYWORDS[790000012$acetylation, 790000344$coiled coil, 790000356$complete proteome, 790000466$dna-binding, 790000467$dna-directed dna polymerase, 790001064$nucleotidyltransferase, 790001065$nucleus, 790001162$phosphoprotein, 790001212$polymorphism, 790001547$transferase]
chromatin accessibility complex 1,UP_SEQ_FEATURE[850011318$chain:Chromatin accessibility complex protein 1, 850106258$modified residue, 850117295$sequence variant]
chromatin modifying protein 5,INTERPRO[450004493$IPR005024:Snf7]
chromatin modifying protein 5,KEGG_PATHWAY[470038841$hsa04144:Endocytosis]
chromatin modifying protein 5,PIR_SUPERFAMILY[630022941$PIRSF030206:ESCRT-3 complex, Chmp4/Chmp5/Chmp6 subunits, 630031004$PIRSF500852:ESCRT-3 complex, Chmp5 subunit]
chromatin modifying protein 5,SP_PIR_KEYWORDS[790000344$coiled coil, 790000356$complete proteome, 790000407$cytoplasm, 790000501$endosome, 790000919$membrane, 790001162$phosphoprotein, 790001212$polymorphism, 790001266$protein transport, 790001558$transport]
chromatin modifying protein 5,UP_SEQ_FEATURE[850010891$chain:Charged multivesicular body protein 5, 850106258$modified residue, 850113035$region of interest:Interaction with VTA1, 850117294$sequence conflict, 850117295$sequence variant]
chromosome 1 open reading frame 113,INTERPRO[450001294$IPR001452:Src homology-3 domain]
chromosome 1 open reading frame 113,SMART[760000295$SM00326:SH3]
chromosome 1 open reading frame 66,INTERPRO[450001540$IPR001737:Ribosomal RNA adenine methylase transferase]
chromosome 1 open reading frame 66,SMART[760000565$SM00650:rADc]
chromosome 1 open reading frame 66,SP_PIR_KEYWORDS[790000344$coiled coil, 790000356$complete proteome, 790000919$membrane, 790001212$polymorphism, 790001555$transmembrane]
chromosome 1 open reading frame 66,UP_SEQ_FEATURE[850096686$chain:UPF0431 protein C1orf66, 850117294$sequence conflict, 850117295$sequence variant, 850118623$transmembrane region]
chromosome 17 open reading frame 91,SP_PIR_KEYWORDS[790000356$complete proteome]
chromosome 17 open reading frame 91,UP_SEQ_FEATURE[850055239$chain:Putative uncharacterized protein C17orf91, 850117294$sequence conflict]
chromosome 19 open reading frame 22,INTERPRO[450001219$IPR001374:Single-stranded nucleic acid binding R3H]
chromosome 19 open reading frame 22,SMART[760000345$SM00393:R3H]
chromosome 19 open reading frame 22,SP_PIR_KEYWORDS[790000356$complete proteome, 790001065$nucleus]
chromosome 19 open reading frame 22,UP_SEQ_FEATURE[850056504$chain:R3H domain-containing protein C19orf22, 850102404$compositionally biased region:Arg-rich, 850105134$domain:R3H]
chromosome 19 open reading frame 40,SP_PIR_KEYWORDS[790000356$complete proteome, 790000452$DNA damage, 790000459$dna repair, 790000466$dna-binding, 790001065$nucleus, 790001212$polymorphism]
chromosome 19 open reading frame 40,UP_SEQ_FEATURE[850018972$chain:Fanconi anemia-associated protein of 24 kDa, 850114564$region of interest:RuvA domain 2-like, 850117295$sequence variant]
chromosome 19 open reading frame 60,SP_PIR_KEYWORDS[790000053$alternative splicing, 790000356$complete proteome]
chromosome 19 open reading frame 60,UP_SEQ_FEATURE[850073528$chain:Uncharacterized protein C19orf60, 850118574$splice variant]
chromosome 2 open reading frame 16,SP_PIR_KEYWORDS[790000356$complete proteome, 790001162$phosphoprotein, 790001212$polymorphism, 790001304$repeat]
chromosome 2 open reading frame 16,UP_SEQ_FEATURE[850073931$chain:Uncharacterized protein C2orf16, 850102404$compositionally biased region:Arg-rich, 850106258$modified residue, 850110164$region of interest:27 X 8 AA approximative tandem repeat of P-S-E-R-S-H-H-S, 850115074$repeat:1, 850115131$repeat:10, 850115147$repeat:11, 850115162$repeat:12, 850115175$repeat:13, 850115188$repeat:14, 850115201$repeat:15, 850115216$repeat:16, 850115231$repeat:17, 850115245$repeat:18, 850115257$repeat:19, 850115273$repeat:2, 850115331$repeat:20, 850115343$repeat:21, 850115355$repeat:22, 850115367$repeat:23, 850115380$repeat:24, 850115392$repeat:25, 850115404$repeat:26, 850115408$repeat:27, 850115417$repeat:3, 850115467$repeat:4, 850115506$repeat:5, 850115534$repeat:6, 850115553$repeat:7, 850115571$repeat:8, 850115588$repeat:9, 850117294$sequence conflict, 850117295$sequence variant]
chromosome 20 open reading frame 166,SP_PIR_KEYWORDS[790000356$complete proteome, 790001212$polymorphism]
chromosome 20 open reading frame 166,UP_SEQ_FEATURE[850073712$chain:Uncharacterized protein C20orf166, 850117295$sequence variant]
chromosome 3 open reading frame 48,INTERPRO[450001711$IPR001932:Protein phosphatase 2C-related, 450014091$IPR015655:Protein phosphatase 2C]
chromosome 3 open reading frame 48,SMART[760000300$SM00331:PP2C_SIG, 760000301$SM00332:PP2Cc]
chromosome 3 open reading frame 52,SP_PIR_KEYWORDS[790000053$alternative splicing, 790000356$complete proteome, 790000499$endoplasmic reticulum, 790000919$membrane, 790001212$polymorphism, 790001555$transmembrane]
chromosome 3 open reading frame 52,UP_SEQ_FEATURE[850064805$chain:TPA-induced transmembrane protein, 850117294$sequence conflict, 850117295$sequence variant, 850118574$splice variant, 850118623$transmembrane region]
chromosome 5 open reading frame 53,SP_PIR_KEYWORDS[790000356$complete proteome, 790001363$Secreted, 790001405$signal]
chromosome 5 open reading frame 53,UP_SEQ_FEATURE[850025531$chain:IgA-inducing protein homolog, 850117814$signal peptide]
chromosome 6 open reading frame 108,INTERPRO[450007065$IPR007710:Nucleoside 2-deoxyribosyltransferase]
chromosome 6 open reading frame 108,PIR_SUPERFAMILY[630028710$PIRSF037191:nucleoside 2-deoxyribosyltransferase, Rcl type]
chromosome 6 open reading frame 108,SP_PIR_KEYWORDS[790000356$complete proteome, 790000407$cytoplasm, 790000617$glycosidase, 790000743$hydrolase, 790001062$nucleotide metabolism, 790001065$nucleus, 790001162$phosphoprotein]
chromosome 6 open reading frame 108,UP_SEQ_FEATURE[850000555$binding site:Substrate, 850014880$chain:Deoxyribonucleoside 5'-monophosphate N- glycosidase, 850106258$modified residue]
coagulation factor II (thrombin) receptor-like 1,INTERPRO[450000240$IPR000276:7TM GPCR, rhodopsin-like, 450002027$IPR002281:Protease-activated receptor 2, 450003437$IPR003912:Protease-activated receptor, 450015778$IPR017452:GPCR, rhodopsin-like superfamily]
coagulation factor II (thrombin) receptor-like 1,KEGG_PATHWAY[470038833$hsa04080:Neuroactive ligand-receptor interaction]
coagulation factor II (thrombin) receptor-like 1,PIR_SUPERFAMILY[630029569$PIRSF037996:proteinase-activated receptor, 630031207$PIRSF800006:rhodopsin-like G protein-coupled receptors]
coagulation factor II (thrombin) receptor-like 1,SP_PIR_KEYWORDS[790000264$cell membrane, 790000356$complete proteome, 790000447$disulfide bond, 790000575$g-protein coupled receptor, 790000616$glycoprotein, 790000919$membrane, 790001162$phosphoprotein, 790001212$polymorphism, 790001252$Protease, 790001301$receptor, 790001405$signal, 790001546$transducer, 790001555$transmembrane]
coagulation factor II (thrombin) receptor-like 1,UP_SEQ_FEATURE[850048652$chain:Proteinase-activated receptor 2, 850102581$compositionally biased region:Poly-Ser, 850102883$disulfide bond, 850105770$glycosylation site:N-linked (GlcNAc...), 850106258$modified residue, 850109698$propeptide:Removed for receptor activation, 850117294$sequence conflict, 850117295$sequence variant, 850117814$signal peptide, 850118130$site:Cleavage; by trypsin, 850118577$topological domain:Cytoplasmic, 850118583$topological domain:Extracellular, 850118623$transmembrane region]
coagulation factor VIII-associated (intronic transcript) 2; coagulation factor VIII-associated (intronic transcript) 3; coagulation factor VIII-associated (intronic transcript) 1,PIR_SUPERFAMILY[630016142$PIRSF019545:factor VIII intron 22 protein]
coagulation factor VIII-associated (intronic transcript) 2; coagulation factor VIII-associated (intronic transcript) 3; coagulation factor VIII-associated (intronic transcript) 1,SP_PIR_KEYWORDS[790000012$acetylation, 790000356$complete proteome]
coagulation factor VIII-associated (intronic transcript) 2; coagulation factor VIII-associated (intronic transcript) 3; coagulation factor VIII-associated (intronic transcript) 1,UP_SEQ_FEATURE[850018906$chain:Factor VIII intron 22 protein, 850106258$modified residue, 850117294$sequence conflict]
coiled-coil domain containing 54,SP_PIR_KEYWORDS[790000344$coiled coil, 790000356$complete proteome, 790001162$phosphoprotein, 790001212$polymorphism]
coiled-coil domain containing 54,UP_SEQ_FEATURE[850012024$chain:Coiled-coil domain-containing protein 54, 850106258$modified residue, 850117295$sequence variant]
complement component 1, q subcomponent, C chain,INTERPRO[450000941$IPR001073:Complement C1q protein, 450007490$IPR008160:Collagen triple helix repeat, 450008180$IPR008983:Tumour necrosis factor-like]
complement component 1, q subcomponent, C chain,KEGG_PATHWAY[470038859$hsa04610:Complement and coagulation cascades, 470038895$hsa05020:Prion diseases, 470038916$hsa05322:Systemic lupus erythematosus]
complement component 1, q subcomponent, C chain,OMIM_DISEASE[520000718$C1q deficiency, type C]
complement component 1, q subcomponent, C chain,PIR_SUPERFAMILY[630002593$PIRSF002477:complement subcomponent C1q chain A]
complement component 1, q subcomponent, C chain,SMART[760000097$SM00110:C1Q]
complement component 1, q subcomponent, C chain,SP_PIR_KEYWORDS[790000002$3d-structure, 790000345$collagen, 790000355$complement pathway, 790000356$complete proteome, 790000445$direct protein sequencing, 790000446$disease mutation, 790000447$disulfide bond, 790000616$glycoprotein, 790000701$homodimer, 790000745$hydroxylation, 790000746$hydroxylysine, 790000747$hydroxyproline, 790000763$immune response, 790000777$innate immunity, 790001191$plasma, 790001304$repeat, 790001363$Secreted, 790001405$signal, 790001568$triple helix]
complement component 1, q subcomponent, C chain,UP_SEQ_FEATURE[850012306$chain:Complement C1q subcomponent subunit C, 850102883$disulfide bond, 850103196$domain:C1q, 850103389$domain:Collagen-like, 850105818$glycosylation site:O-linked (Gal...), 850106258$modified residue, 850117294$sequence conflict, 850117295$sequence variant, 850117814$signal peptide, 850118575$strand, 850118624$turn]
cyclin-dependent kinase 10,INTERPRO[450000618$IPR000719:Protein kinase, core, 450002035$IPR002290:Serine/threonine protein kinase, 450007563$IPR008271:Serine/threonine protein kinase, active site, 450015769$IPR017441:Protein kinase, ATP binding site, 450015770$IPR017442:Serine/threonine protein kinase-related]
cyclin-dependent kinase 10,PIR_SUPERFAMILY[630000671$PIRSF000564:kinase-related transforming protein]
cyclin-dependent kinase 10,SMART[760000193$SM00220:S_TKc]
cyclin-dependent kinase 10,SP_PIR_KEYWORDS[790000053$alternative splicing, 790000134$ATP, 790000138$atp-binding, 790000260$cell division, 790000356$complete proteome, 790000389$cyclin, 790000825$kinase, 790001063$nucleotide-binding, 790001162$phosphoprotein, 790001168$phosphotransferase, 790001212$polymorphism, 790001388$serine/threonine-protein kinase, 790001547$transferase]
cyclin-dependent kinase 10,UP_SEQ_FEATURE[850000114$active site:Proton acceptor, 850000242$binding site:ATP, 850010428$chain:Cell division protein kinase 10, 850105086$domain:Protein kinase, 850106258$modified residue, 850106263$nucleotide phosphate-binding region:ATP, 850117295$sequence variant, 850118574$splice variant]
cytochrome P450, family 7, subfamily A, polypeptide 1,BIOCARTA[30000118$h_fxrPathway:FXR and LXR Regulation of Cholesterol Metabolism, 30000211$h_nuclearRsPathway:Nuclear Receptors in Lipid Metabolism and Toxicity]
cytochrome P450, family 7, subfamily A, polypeptide 1,COG_ONTOLOGY[90000104$Secondary metabolites biosynthesis, transport, and catabolism]
cytochrome P450, family 7, subfamily A, polypeptide 1,INTERPRO[450000989$IPR001128:Cytochrome P450, 450002136$IPR002403:Cytochrome P450, E-class, group IV, 450016280$IPR017972:Cytochrome P450, conserved site, 450016281$IPR017973:Cytochrome P450, C-terminal region]
cytochrome P450, family 7, subfamily A, polypeptide 1,KEGG_PATHWAY[470038737$hsa00120:Primary bile acid biosynthesis, 470038739$hsa00140:Steroid hormone biosynthesis, 470038821$hsa03320:PPAR signaling pathway]
cytochrome P450, family 7, subfamily A, polypeptide 1,PIR_SUPERFAMILY[630000060$PIRSF000047:cytochrome P450, CYP7A1 type, 630030816$PIRSF500625:cytochrome P450 7A1]
cytochrome P450, family 7, subfamily A, polypeptide 1,SP_PIR_KEYWORDS[790000002$3d-structure, 790000305$cholesterol metabolism, 790000314$chromoprotein, 790000356$complete proteome, 790000488$electron transfer, 790000499$endoplasmic reticulum, 790000652$heme, 790000802$iron, 790000873$lipid metabolism, 790000919$membrane, 790000937$metal-binding, 790000943$metalloprotein, 790000959$microsome, 790000984$Monooxygenase, 790001008$nadp, 790001092$oxidoreductase, 790001212$polymorphism, 790001442$steroid metabolism, 790001556$transmembrane protein]
cytochrome P450, family 7, subfamily A, polypeptide 1,UP_SEQ_FEATURE[850011193$chain:Cholesterol 7-alpha-monooxygenase, 850105852$helix, 850106026$metal ion-binding site:Iron (heme axial ligand), 850117294$sequence conflict, 850117295$sequence variant, 850118575$strand, 850118624$turn]
dachsous 2 (Drosophila),INTERPRO[450001884$IPR002126:Cadherin]
dachsous 2 (Drosophila),SMART[760000099$SM00112:CA]
dachsous 2 (Drosophila),SP_PIR_KEYWORDS[790000053$alternative splicing, 790000211$calcium, 790000256$cell adhesion, 790000356$complete proteome, 790000616$glycoprotein, 790000919$membrane, 790001212$polymorphism, 790001304$repeat, 790001555$transmembrane]
dachsous 2 (Drosophila),UP_SEQ_FEATURE[850048758$chain:Protocadherin-23, 850103211$domain:Cadherin 1, 850103212$domain:Cadherin 10, 850103213$domain:Cadherin 11, 850103214$domain:Cadherin 12, 850103215$domain:Cadherin 13, 850103216$domain:Cadherin 14, 850103217$domain:Cadherin 15, 850103218$domain:Cadherin 16, 850103219$domain:Cadherin 17, 850103220$domain:Cadherin 18, 850103221$domain:Cadherin 19, 850103222$domain:Cadherin 2, 850103223$domain:Cadherin 20, 850103224$domain:Cadherin 21, 850103225$domain:Cadherin 22, 850103233$domain:Cadherin 3, 850103239$domain:Cadherin 4, 850103240$domain:Cadherin 5, 850103241$domain:Cadherin 6, 850103242$domain:Cadherin 7, 850103243$domain:Cadherin 8, 850103244$domain:Cadherin 9, 850105770$glycosylation site:N-linked (GlcNAc...), 850117294$sequence conflict, 850117295$sequence variant, 850118574$splice variant, 850118623$transmembrane region]
dedicator of cytokinesis 8,INTERPRO[450009747$IPR010703:Dedicator of cytokinesis]
dedicator of cytokinesis 8,OMIM_DISEASE[520003160$Mental retardation, autosomal dominant 2]
dedicator of cytokinesis 8,SP_PIR_KEYWORDS[790000053$alternative splicing, 790000356$complete proteome, 790000641$guanine-nucleotide releasing factor, 790001162$phosphoprotein, 790001212$polymorphism]
dedicator of cytokinesis 8,UP_SEQ_FEATURE[850014452$chain:Dedicator of cytokinesis protein 8, 850103522$domain:DHR-1, 850103523$domain:DHR-2, 850106258$modified residue, 850117294$sequence conflict, 850117295$sequence variant, 850118574$splice variant]
deoxyribonuclease I-like 1,INTERPRO[450004603$IPR005135:Endonuclease/exonuclease/phosphatase, 450007506$IPR008185:Deoxyribonuclease I, eukaryotic, 450014526$IPR016202:Deoxyribonuclease I-like, 450016360$IPR018057:Deoxyribonuclease I, active site]
deoxyribonuclease I-like 1,PIR_SUPERFAMILY[630001140$PIRSF000988:deoxyribonuclease I, 630001141$PIRSF000988:DNase_I_euk]
deoxyribonuclease I-like 1,SMART[760000421$SM00476:DNaseIc]
deoxyribonuclease I-like 1,SP_PIR_KEYWORDS[790000356$complete proteome, 790000447$disulfide bond, 790000498$Endonuclease, 790000499$endoplasmic reticulum, 790000616$glycoprotein, 790000743$hydrolase, 790001049$nuclease, 790001212$polymorphism, 790001405$signal]
deoxyribonuclease I-like 1,UP_SEQ_FEATURE[850014875$chain:Deoxyribonuclease-1-like 1, 850102883$disulfide bond, 850105770$glycosylation site:N-linked (GlcNAc...), 850117294$sequence conflict, 850117295$sequence variant, 850117814$signal peptide]
discs, large homolog 4 (Drosophila),BIOCARTA[30000206$h_nos1Pathway:Nitric Oxide Signaling Pathway, 30000223$h_PDZsPathway:Synaptic Proteins at the Synaptic Junction]
discs, large homolog 4 (Drosophila),INTERPRO[450001294$IPR001452:Src homology-3 domain, 450001316$IPR001478:PDZ/DHR/GLGF, 450007477$IPR008144:Guanylate kinase, 450007478$IPR008145:Guanylate kinase/L-type calcium channel region, 450010373$IPR011511:Variant SH3, 450014637$IPR016313:Membrane-associated guanylate kinase (MAGUK) scaffold protein, 450017820$IPR019583:PDZ-associated domain of NMDA receptors, 450017823$IPR019586:Guanylate kinase-associated, C-terminal, 450017827$IPR019590:Membrane-associated guanylate kinase (MAGUK), PEST domain, N-terminal]
discs, large homolog 4 (Drosophila),KEGG_PATHWAY[470038894$hsa05016:Huntington's disease]
discs, large homolog 4 (Drosophila),PIR_SUPERFAMILY[630001879$PIRSF001741:MAGUK_DLGH]
discs, large homolog 4 (Drosophila),SMART[760000063$SM00072:GuKc, 760000200$SM00228:PDZ, 760000295$SM00326:SH3]
discs, large homolog 4 (Drosophila),SP_PIR_KEYWORDS[790000002$3d-structure, 790000053$alternative splicing, 790000263$cell junction, 790000264$cell membrane, 790000356$complete proteome, 790000881$lipoprotein, 790000919$membrane, 790001100$palmitate, 790001162$phosphoprotein, 790001223$postsynaptic cell membrane, 790001304$repeat, 790001398$sh3 domain, 790001475$synapse]
discs, large homolog 4 (Drosophila),UP_SEQ_FEATURE[850015431$chain:Disks large homolog 4, 850104093$domain:Guanylate kinase-like, 850104919$domain:PDZ 1, 850104924$domain:PDZ 2, 850104925$domain:PDZ 3, 850105350$domain:SH3, 850105852$helix, 850105898$lipid moiety-binding region:S-palmitoyl cysteine, 850106258$modified residue, 850118574$splice variant, 850118575$strand]
dynein, axonemal, heavy chain 1,COG_ONTOLOGY[90000053$Cytoskeleton]
dynein, axonemal, heavy chain 1,INTERPRO[450003782$IPR004273:Dynein heavy chain, 450010532$IPR011704:ATPase associated with various cellular activities, AAA-5, 450012226$IPR013602:Dynein heavy chain, N-terminal region 2]
dynein, axonemal, heavy chain 1,KEGG_PATHWAY[470038894$hsa05016:Huntington's disease]
dynein, axonemal, heavy chain 1,SP_PIR_KEYWORDS[790000053$alternative splicing, 790000138$atp-binding, 790000267$cell projection, 790000321$cilium, 790000344$coiled coil, 790000356$complete proteome, 790000407$cytoplasm, 790000410$cytoskeleton, 790000475$dynein, 790000853$leucine-rich repeat, 790000960$microtubule, 790000986$motor protein, 790001063$nucleotide-binding, 790001162$phosphoprotein, 790001212$polymorphism, 790001304$repeat]
dynein, axonemal, heavy chain 1,UP_SEQ_FEATURE[850016515$chain:Dynein heavy chain 1, axonemal, 850102572$compositionally biased region:Poly-Glu, 850106258$modified residue, 850106263$nucleotide phosphate-binding region:ATP, 850110798$region of interest:AAA 1, 850110799$region of interest:AAA 2, 850110800$region of interest:AAA 3, 850110801$region of interest:AAA 4, 850110802$region of interest:AAA 5, 850110803$region of interest:AAA 6, 850114695$region of interest:Stalk, 850114697$region of interest:Stem, 850116308$repeat:LRR 1, 850116309$repeat:LRR 10, 850116310$repeat:LRR 11, 850116311$repeat:LRR 12, 850116312$repeat:LRR 13, 850116313$repeat:LRR 14, 850116314$repeat:LRR 15, 850116315$repeat:LRR 16, 850116316$repeat:LRR 17, 850116317$repeat:LRR 18, 850116318$repeat:LRR 19, 850116319$repeat:LRR 2, 850116330$repeat:LRR 3, 850116340$repeat:LRR 4, 850116341$repeat:LRR 5, 850116342$repeat:LRR 6, 850116343$repeat:LRR 7, 850116344$repeat:LRR 8, 850116346$repeat:LRR 9, 850117294$sequence conflict, 850117295$sequence variant, 850117339$short sequence motif:CFDEFNR motif, 850117472$short sequence motif:GPAGTGKT motif, 850118574$splice variant]
enoyl Coenzyme A hydratase domain containing 1,COG_ONTOLOGY[90000084$Lipid metabolism]
enoyl Coenzyme A hydratase domain containing 1,INTERPRO[450001553$IPR001753:Crotonase, core, 450016658$IPR018376:Enoyl-CoA hydratase/isomerase, conserved site]
enoyl Coenzyme A hydratase domain containing 1,OMIM_DISEASE[520002020$Genome-wide association study provides evidence for a breast cancer risk locus at 6q22.33]
enoyl Coenzyme A hydratase domain containing 1,SP_PIR_KEYWORDS[790000053$alternative splicing, 790000356$complete proteome, 790000810$Isomerase]
enoyl Coenzyme A hydratase domain containing 1,UP_SEQ_FEATURE[850017503$chain:Enoyl-CoA hydratase domain-containing protein 1, 850118574$splice variant]
ephrin-A2,INTERPRO[450001592$IPR001799:Ephrin, 450008178$IPR008972:Cupredoxin, 450018000$IPR019765:Ephrin, conserved site]
ephrin-A2,KEGG_PATHWAY[470038851$hsa04360:Axon guidance]
ephrin-A2,PIR_SUPERFAMILY[630005696$PIRSF005772:Ephrin-A]
ephrin-A2,SP_PIR_KEYWORDS[790000002$3d-structure, 790000264$cell membrane, 790000356$complete proteome, 790000447$disulfide bond, 790000616$glycoprotein, 790000628$gpi-anchor, 790000881$lipoprotein, 790000919$membrane, 790001405$signal]
ephrin-A2,UP_SEQ_FEATURE[850017629$chain:Ephrin-A2, 850102883$disulfide bond, 850105770$glycosylation site:N-linked (GlcNAc...), 850105856$lipid moiety-binding region:GPI-anchor amidated asparagine, 850109701$propeptide:Removed in mature form, 850117294$sequence conflict, 850117814$signal peptide]
epoxide hydrolase 4,INTERPRO[450000062$IPR000073:Alpha/beta hydrolase fold-1, 450000546$IPR000639:Epoxide hydrolase-like]
epoxide hydrolase 4,SP_PIR_KEYWORDS[790000356$complete proteome, 790000743$hydrolase, 790000919$membrane, 790001212$polymorphism, 790001409$Signal-anchor, 790001555$transmembrane]
epoxide hydrolase 4,UP_SEQ_FEATURE[850000090$active site:Nucleophile, 850000114$active site:Proton acceptor, 850000131$active site:Proton donor, 850017716$chain:Epoxide hydrolase 4, 850117294$sequence conflict, 850117295$sequence variant, 850118623$transmembrane region]
eukaryotic translation initiation factor 2, subunit 3 gamma, 52kDa,BIOCARTA[30000094$h_eif2Pathway:Regulation of eIF2, 30000146$h_igf1mtorpathway:Skeletal muscle hypertrophy is regulated via AKT/mTOR pathway]
eukaryotic translation initiation factor 2, subunit 3 gamma, 52kDa,INTERPRO[450000689$IPR000795:Protein synthesis factor, GTP-binding, 450003671$IPR004161:Translation elongation factor EFTu/EF1A, domain 2, 450013701$IPR015256:Initiation factor eIF2 gamma, C-terminal]
eukaryotic translation initiation factor 2, subunit 3 gamma, 52kDa,PIR_SUPERFAMILY[630003109$PIRSF003021:translation initiation factor eIF-2 gamma chain]
eukaryotic translation initiation factor 2, subunit 3 gamma, 52kDa,SP_PIR_KEYWORDS[790000012$acetylation, 790000356$complete proteome, 790000445$direct protein sequencing, 790000637$GTP binding, 790000639$gtp-binding, 790000776$Initiation factor, 790001059$nucleotide binding, 790001063$nucleotide-binding, 790001097$P-loop, 790001162$phosphoprotein, 790001212$polymorphism, 790001255$protein biosynthesis]
eukaryotic translation initiation factor 2, subunit 3 gamma, 52kDa,UP_SEQ_FEATURE[850018083$chain:Eukaryotic translation initiation factor 2 subunit 3, 850106258$modified residue, 850106296$nucleotide phosphate-binding region:GTP, 850117295$sequence variant]
eukaryotic translation initiation factor 4H,INTERPRO[450000430$IPR000504:RNA recognition motif, RNP-1, 450011357$IPR012677:Nucleotide-binding, alpha-beta plait]
eukaryotic translation initiation factor 4H,SMART[760000328$SM00360:RRM]
eukaryotic translation initiation factor 4H,SP_PIR_KEYWORDS[790000012$acetylation, 790000053$alternative splicing, 790000356$complete proteome, 790000407$cytoplasm, 790000445$direct protein sequencing, 790000733$host-virus interaction, 790000776$Initiation factor, 790001162$phosphoprotein, 790001255$protein biosynthesis, 790001339$rna-binding, 790001640$williams-beuren syndrome]
eukaryotic translation initiation factor 4H,UP_SEQ_FEATURE[850018149$chain:Eukaryotic translation initiation factor 4H, 850105211$domain:RRM, 850106258$modified residue, 850111871$region of interest:HHV-1 Vhs binding site, 850118574$splice variant]
exosome component 7,COG_ONTOLOGY[90000125$Translation, ribosomal structure and biogenesis]
exosome component 7,INTERPRO[450001098$IPR001247:Exoribonuclease, phosphorolytic domain 1, 450014270$IPR015847:Exoribonuclease, phosphorolytic domain 2]
exosome component 7,KEGG_PATHWAY[470038814$hsa03018:RNA degradation]
exosome component 7,PIR_SUPERFAMILY[630006618$PIRSF006657:exosome complex 3'-5' exonuclease]
exosome component 7,SP_PIR_KEYWORDS[790000002$3d-structure, 790000012$acetylation, 790000356$complete proteome, 790000445$direct protein sequencing, 790000523$exonuclease, 790000526$exosome, 790000743$hydrolase, 790001049$nuclease, 790001065$nucleus, 790001212$polymorphism, 790001339$rna-binding, 790001345$rrna processing]
exosome component 7,UP_SEQ_FEATURE[850018277$chain:Exosome complex exonuclease RRP42, 850105852$helix, 850106258$modified residue, 850117295$sequence variant, 850118575$strand, 850118624$turn]
family with sequence similarity 108, member A4; family with sequence similarity 108, member A5; family with sequence similarity 108, member A1,SP_PIR_KEYWORDS[790000053$alternative splicing, 790000356$complete proteome, 790000743$hydrolase, 790001363$Secreted, 790001405$signal]
family with sequence similarity 108, member A4; family with sequence similarity 108, member A5; family with sequence similarity 108, member A1,UP_SEQ_FEATURE[850000011$active site:Charge relay system, 850003167$chain:Abhydrolase domain-containing protein FAM108A1, 850117294$sequence conflict, 850117814$signal peptide, 850118574$splice variant]
family with sequence similarity 132, member A,SP_PIR_KEYWORDS[790000356$complete proteome, 790001212$polymorphism, 790001363$Secreted, 790001405$signal]
family with sequence similarity 132, member A,UP_SEQ_FEATURE[850045865$chain:Protein FAM132A, 850117295$sequence variant, 850117814$signal peptide]
family with sequence similarity 19 (chemokine (C-C motif)-like), member A3,SP_PIR_KEYWORDS[790000053$alternative splicing, 790000356$complete proteome, 790001363$Secreted, 790001405$signal]
family with sequence similarity 19 (chemokine (C-C motif)-like), member A3,UP_SEQ_FEATURE[850045944$chain:Protein FAM19A3, 850117814$signal peptide, 850118574$splice variant]
forkhead box E1 (thyroid transcription factor 2),INTERPRO[450001565$IPR001766:Transcription factor, fork head, 450010816$IPR011991:Winged helix repressor DNA-binding, 450016421$IPR018122:Transcription factor, fork head, conserved site]
forkhead box E1 (thyroid transcription factor 2),OMIM_DISEASE[520000504$Bamforth-Lazarus syndrome]
forkhead box E1 (thyroid transcription factor 2),SMART[760000307$SM00339:FH]
forkhead box E1 (thyroid transcription factor 2),SP_PIR_KEYWORDS[790000356$complete proteome, 790000446$disease mutation, 790000466$dna-binding, 790001065$nucleus, 790001162$phosphoprotein, 790001212$polymorphism, 790001539$Transcription, 790001543$transcription regulation]
forkhead box E1 (thyroid transcription factor 2),UP_SEQ_FEATURE[850019855$chain:Forkhead box protein E1, 850102378$compositionally biased region:Ala-rich, 850102565$compositionally biased region:Poly-Ala, 850102586$compositionally biased region:Pro-rich, 850102914$DNA-binding region:Fork-head, 850117295$sequence variant]
glucokinase (hexokinase 4) regulator,INTERPRO[450004942$IPR005486:Glucokinase regulatory, conserved site]
glucokinase (hexokinase 4) regulator,OMIM_DISEASE[520001123$Common genetic variation near MC4R is associated with waist circumference and insulin resistance, 520001129$Common variants at 30 loci contribute to polygenic dyslipidemia, 520001995$Genome-wide association analysis of metabolic traits in a birth cohort from a founder population, 520002013$Genome-wide association study identifies genes for biomarkers of cardiovascular disease: serum urate and dyslipidemia, 520002930$Loci influencing lipid levels and coronary heart disease risk in 16 European population cohorts, 520002932$Loci Related to Metabolic-Syndrome Pathways Including LEPR, HNF1A, IL6R, and GCKR Associate with Plasma C-Reactive Protein: The Women's Genome Health Study, 520003638$Newly identified loci that influence lipid concentrations and risk of coronary artery disease, 520004490$Six new loci associated with blood low-density lipoprotein cholesterol, high-density lipoprotein cholesterol or triglycerides in humans]
glucokinase (hexokinase 4) regulator,PIR_SUPERFAMILY[630001834$PIRSF001668:glucokinase regulator]
glucokinase (hexokinase 4) regulator,SP_PIR_KEYWORDS[790000356$complete proteome, 790001212$polymorphism, 790001304$repeat]
glucokinase (hexokinase 4) regulator,UP_SEQ_FEATURE[850021375$chain:Glucokinase regulatory protein, 850105364$domain:SIS 1, 850105365$domain:SIS 2, 850117295$sequence variant]
glucosamine-6-phosphate deaminase 1,INTERPRO[450004040$IPR004547:Glucosamine-6-phosphate isomerase, 450005580$IPR006148:Glucosamine/galactosamine-6-phosphate isomerase, 450016605$IPR018321:Glucosamine-6-phosphate isomerase, conserved site, 450016606$IPR018322:Glucosamine-6-phosphate isomerase, subgroup]
glucosamine-6-phosphate deaminase 1,KEGG_PATHWAY[470038770$hsa00520:Amino sugar and nucleotide sugar metabolism]
glucosamine-6-phosphate deaminase 1,PIR_SUPERFAMILY[630001648$PIRSF001483:glucosamine-6-phosphate isomerase]
glucosamine-6-phosphate deaminase 1,SP_PIR_KEYWORDS[790000002$3d-structure, 790000012$acetylation, 790000232$carbohydrate metabolism, 790000356$complete proteome, 790000407$cytoplasm, 790000743$hydrolase]
glucosamine-6-phosphate deaminase 1,UP_SEQ_FEATURE[850000078$active site:For ring-opening step, 850000117$active site:Proton acceptor; for enolization step, 850000122$active site:Proton acceptor; for ring-opening step, 850021403$chain:Glucosamine-6-phosphate isomerase 1, 850105852$helix, 850106258$modified residue, 850118575$strand, 850118624$turn]
glucosidase, beta (bile acid) 2,INTERPRO[450006182$IPR006775:Glucosylceramidase, 450013084$IPR014551:Beta-glucosidase, GBA2 type]
glucosidase, beta (bile acid) 2,PIR_SUPERFAMILY[630021788$PIRSF028944:beta-glucosidase, GBA2 type, 630021789$PIRSF028944:Beta_gluc_GBA2]
glucosidase, beta (bile acid) 2,SP_PIR_KEYWORDS[790000053$alternative splicing, 790000264$cell membrane, 790000356$complete proteome, 790000445$direct protein sequencing, 790000616$glycoprotein, 790000617$glycosidase, 790000743$hydrolase, 790000873$lipid metabolism, 790000919$membrane, 790001428$sphingolipid metabolism, 790001555$transmembrane]
glucosidase, beta (bile acid) 2,UP_SEQ_FEATURE[850034571$chain:Non-lysosomal glucosylceramidase, 850105770$glycosylation site:N-linked (GlcNAc...), 850117294$sequence conflict, 850118574$splice variant, 850118577$topological domain:Cytoplasmic, 850118583$topological domain:Extracellular, 850118623$transmembrane region]
glutamate receptor, ionotropic, delta 1,INTERPRO[450001163$IPR001320:Ionotropic glutamate receptor, 450001341$IPR001508:NMDA receptor, 450001618$IPR001828:Extracellular ligand-binding receptor, 450014119$IPR015683:Glutamate receptor-related, 450014509$IPR016160:Aldehyde dehydrogenase, conserved site, 450017831$IPR019594:Glutamate receptor, L-glutamate/glycine-binding]
glutamate receptor, ionotropic, delta 1,KEGG_PATHWAY[470038833$hsa04080:Neuroactive ligand-receptor interaction]
glutamate receptor, ionotropic, delta 1,PIR_SUPERFAMILY[630028588$PIRSF037089:ionotropic glutamate receptor delta]
glutamate receptor, ionotropic, delta 1,SMART[760000069$SM00079:PBPe]
glutamate receptor, ionotropic, delta 1,SP_PIR_KEYWORDS[790000263$cell junction, 790000264$cell membrane, 790000356$complete proteome, 790000616$glycoprotein, 790000798$ion transport, 790000799$ionic channel, 790000919$membrane, 790001162$phosphoprotein, 790001212$polymorphism, 790001223$postsynaptic cell membrane, 790001301$receptor, 790001405$signal, 790001475$synapse, 790001555$transmembrane, 790001558$transport]
glutamate receptor, ionotropic, delta 1,UP_SEQ_FEATURE[850021564$chain:Glutamate receptor delta-1 subunit, 850105770$glycosylation site:N-linked (GlcNAc...), 850106258$modified residue, 850117295$sequence variant, 850117814$signal peptide, 850118577$topological domain:Cytoplasmic, 850118583$topological domain:Extracellular, 850118623$transmembrane region]
glutamate-rich 1,SP_PIR_KEYWORDS[790000012$acetylation, 790000356$complete proteome, 790001162$phosphoprotein, 790001212$polymorphism]
glutamate-rich 1,UP_SEQ_FEATURE[850021614$chain:Glutamate-rich protein 1, 850102507$compositionally biased region:Glu-rich, 850106258$modified residue, 850117294$sequence conflict, 850117295$sequence variant]
glutamine-fructose-6-phosphate transaminase 2,INTERPRO[450000496$IPR000583:Glutamine amidotransferase, class-II, 450001189$IPR001347:Sugar isomerase (SIS), 450005299$IPR005855:Glucosamine-fructose-6-phosphate aminotransferase, isomerising, 450016245$IPR017932:Glutamine amidotransferase, type II]
glutamine-fructose-6-phosphate transaminase 2,KEGG_PATHWAY[470038745$hsa00250:Alanine, aspartate and glutamate metabolism, 470038770$hsa00520:Amino sugar and nucleotide sugar metabolism]
glutamine-fructose-6-phosphate transaminase 2,PIR_SUPERFAMILY[630000620$PIRSF000520:glutamine-fructose-6-phosphate aminotransferase (isomerizing)]
glutamine-fructose-6-phosphate transaminase 2,SP_PIR_KEYWORDS[790000070$Aminotransferase, 790000356$complete proteome, 790000599$glutamine amidotransferase, 790001162$phosphoprotein, 790001212$polymorphism, 790001304$repeat, 790001547$transferase]
glutamine-fructose-6-phosphate transaminase 2,UP_SEQ_FEATURE[850000050$active site:For GATase activity, 850021397$chain:Glucosamine--fructose-6-phosphate aminotransferase [isomerizing] 2, 850104057$domain:Glutamine amidotransferase type-2, 850105364$domain:SIS 1, 850105365$domain:SIS 2, 850106258$modified residue, 850117295$sequence variant]
guanosine monophosphate reductase 2,INTERPRO[450000958$IPR001093:IMP dehydrogenase/GMP reductase, 450005437$IPR005993:Guanosine monophosphate reductase 1, 450012397$IPR013785:Aldolase-type TIM barrel, 450014298$IPR015875:IMP dehydrogenase / GMP reductase, conserved site]
guanosine monophosphate reductase 2,KEGG_PATHWAY[470038742$hsa00230:Purine metabolism]
guanosine monophosphate reductase 2,PIR_SUPERFAMILY[630000277$PIRSF000235:GMP reductase, 630000278$PIRSF000235:GMP_reductase]
guanosine monophosphate reductase 2,SP_PIR_KEYWORDS[790000002$3d-structure, 790000012$acetylation, 790000356$complete proteome, 790000937$metal-binding, 790001008$nadp, 790001092$oxidoreductase, 790001212$polymorphism, 790001226$potassium]
guanosine monophosphate reductase 2,UP_SEQ_FEATURE[850000165$active site:Thioimidate intermediate, 850000461$binding site:NADP, 850022195$chain:GMP reductase 2, 850105852$helix, 850106211$metal ion-binding site:Potassium; via carbonyl oxygen, 850106258$modified residue, 850106307$nucleotide phosphate-binding region:NADP, 850117294$sequence conflict, 850117295$sequence variant, 850118575$strand, 850118624$turn]
guanylate binding protein 4,INTERPRO[450002808$IPR003191:Guanylate-binding protein, C-terminal, 450014315$IPR015894:Guanylate-binding protein, N-terminal]
guanylate binding protein 4,PIR_SUPERFAMILY[630005479$PIRSF005552:guanine nucleotide-binding protein 1]
guanylate binding protein 4,SP_PIR_KEYWORDS[790000012$acetylation, 790000344$coiled coil, 790000356$complete proteome, 790000407$cytoplasm, 790000639$gtp-binding, 790001063$nucleotide-binding, 790001212$polymorphism]
guanylate binding protein 4,UP_SEQ_FEATURE[850022800$chain:Guanylate-binding protein 4, 850102585$compositionally biased region:Poly-Val, 850106258$modified residue, 850106296$nucleotide phosphate-binding region:GTP, 850117294$sequence conflict, 850117295$sequence variant]
headcase homolog (Drosophila),SP_PIR_KEYWORDS[790000356$complete proteome, 790000428$developmental protein, 790001162$phosphoprotein]
headcase homolog (Drosophila),UP_SEQ_FEATURE[850023018$chain:Headcase protein homolog, 850102390$compositionally biased region:Ala/Gly-rich, 850106258$modified residue]
heat shock 70kDa protein 1A; heat shock 70kDa protein 1B,BBID[10000018$114.Genomic_reformatting_Brain_Ischemia]
heat shock 70kDa protein 1A; heat shock 70kDa protein 1B,BIOCARTA[30000216$h_p53hypoxiaPathway:Hypoxia and p53 in the Cardiovascular system, 30000235$h_pparaPathway:Mechanism of Gene Regulation by Peroxisome Proliferators via PPARa(alpha), 30000296$h_tidPathway:Chaperones modulate interferon Signaling Pathway]
heat shock 70kDa protein 1A; heat shock 70kDa protein 1B,INTERPRO[450000896$IPR001023:Heat shock protein Hsp70, 450011768$IPR013126:Heat shock protein 70, 450016471$IPR018181:Heat shock protein 70, conserved site]
heat shock 70kDa protein 1A; heat shock 70kDa protein 1B,KEGG_PATHWAY[470038818$hsa03040:Spliceosome, 470038827$hsa04010:MAPK signaling pathway, 470038841$hsa04144:Endocytosis, 470038860$hsa04612:Antigen processing and presentation, 470038895$hsa05020:Prion diseases]
heat shock 70kDa protein 1A; heat shock 70kDa protein 1B,PIR_SUPERFAMILY[630002695$PIRSF002581:chaperone HSP70]
heat shock 70kDa protein 1A; heat shock 70kDa protein 1B,SP_PIR_KEYWORDS[790000002$3d-structure, 790000012$acetylation, 790000134$ATP, 790000138$atp-binding, 790000288$Chaperone, 790000356$complete proteome, 790000407$cytoplasm, 790000445$direct protein sequencing, 790000976$molecular chaperone, 790001063$nucleotide-binding, 790001162$phosphoprotein, 790001212$polymorphism, 790001450$stress response]
heat shock 70kDa protein 1A; heat shock 70kDa protein 1B,UP_SEQ_FEATURE[850023044$chain:Heat shock 70 kDa protein 1A/1B, 850105852$helix, 850106258$modified residue, 850117294$sequence conflict, 850117295$sequence variant, 850118575$strand, 850118624$turn]
